Pharmaceutical Filtration Market - Global Forecast To 2029
商品番号 : SMB-28481
| 出版社 | MarketsandMarkets |
| 出版年月 | 2024年12月 |
| ページ数 | 646 |
| 図表数 | 1004 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
Report Overview
The global pharmaceutical filtration market is projected to reach USD 20.97 billion by 2029 from USD 13.31 billion in 2024, at a CAGR of 9.5% during the forecast period of 2024 to 2029. The growth of the oral proteins and peptides market has been significantly driven by increasing R&D investment by key players for the development biopharmaceutical drugs and growing adoption of continuous manufacturing process . However, requirement of high capital investments for new production facilities are restraining market growth.
世界の医薬品用ろ過市場は、2024年から2029年の予測期間中に9.5%のCAGRで、2024年の133億1,000万米ドルから2029年までに209億7,000万米ドルに達すると予測されています。

“The sterile filtration segment accounted for the largest share by type in 2023.”
Sterile filtration segment accounted for largest share of the market due to increasing focus on development of advanced therapies and rising focus on biomedical research. These increasing focus on biomedical research drives the demand for sterile filtration technologies to maintain sterile conditions and prevent cross-contamination for the production and manufacturing of biopharmaceuticals. Additionally, increasing approval biologics and biosimilars is driving the need of sterile filtration. Moreover, increasing vaccine production for the treatments of several diseases such as infectious diseases is promoting the segment growth in pharmaceutical filtration market.
“The US has continued to dominate the pharmaceutical filtration market during the forecast period of 2024-2029.”
The US is the world’s largest biopharmaceutical market and a leader in biopharmaceutical research/investments. Driven by the growing patient population suffering from infectious disease, increasing biopharmaceuticals’ importance, and the necessity of safe and high-quality products in the healthcare sector, growing investments and funding in biomedical research by government bodies and pharmaceutical & biotechnology companies. Also, a strong established presence of several market players in the region is another key factor supporting market growth. These key companies include, Danaher Corporation (US), Thermo Fisher Scientific Inc. (US), 3M Company (US).

The primary interviews conducted for this report can be categorized as follows:
- By Respondent: Supply Side- 70% and Demand Side 30%
- By Designation: Managers – 45%, CXO & Directors – 30%, and Executives – 25%
- By Region: North America -40%, Europe -25%, Asia-Pacific -25%, Latin America -5% and Middle East & Africa- 5%
List of key Companies Profiled in the Report:
Danaher Corporation (US), Merck KGaA (Germany), Sartorius AG (Germany), 3M Company (US), Repligen Corporation (US), Parker Hannifin Corporation (US), Eaton Corporation plc (Ireland), Thermo Fisher Scientific, Inc. (US), Donaldson Company, Inc. (US), Porvair PLC (UK), Alfa Laval Corporate AB (Sweden), Corning Incorporated (US), MANN+HUMMEL (Germany), Saint-Gobain (France), STERIS plc (US), Meissner Filtration Products, Inc. (US), Amazon Filters Ltd. (UK), Graver Technologies, LLC. (US), MMS AG (Switzerland), ErtelAlsop (US), Kasag Swiss AG (Switzerland), Freudenberg Filtration Technologies SE & Co. KG (Germany), Cole-Parmer Instrument Company, LLC (US), Filtrox AG (Switzerland), Membrane Solutions (US).

Research Coverage:
This research report categorizes the oral proteins and peptides market by Product )Consumables (Filters (Membrane Filters, Depth Filters, Air Filter, Virus Filter, and Other Filters) and Other Consumables (Filtration Assemblies, Filter Holders, and Filtration Acccessories) and Systems (Single-Use Systems and Reuseable Systems)), by Technique (Microfiltration, Ultrafiltration, Nanofiltration, and Other Techniques), by Type (Sterile Filtration and Non-Sterile Filtration) by Application (Final Product Processing (Active Pharmaceutical Ingredient Filtration, Protein Purification, Vaccines and Antibody Processing, Formulation and Filling Solutions, and Viral Clearance), Raw Material Filtration (Media Buffer filtration, Pre-Filtration, and Bioburden Testing), Cell Separation, Water Purification, and Air Purification) and by region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the oral proteins and peptides market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products, solutions, key strategies, collaborations, partnerships, and agreements. New launches, collaborations and acquisitions, and recent developments associated with the oral proteins and peptides market.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall pharmaceutical filtration market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
- Analysis of key drivers (Growing pharmaceutical industry, Rising R&D spending in pharmaceutical and biotechnology industries, Increasing adoption of single-use technologies, Increasing purity requirement in pharmaceutical and biotechnology manufacturing, and Adoption of a continuous manufacturing process), restraints (Membrane fouling issues, Requirement of high capital investment for new production facilities, and Technological limitations), opportunities (Growth opportunities in emerging economies, Advances in nanofiber technology, and Growing need for high-efficiency filters for vaccine production), and Challenges (Increased cost and reduced speed and yield of filters, Survival of small players and new entrants, and Stringent regulatory compliance).
- Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the pharmaceutical filtration market.
- Market Development: Comprehensive information about lucrative markets – the report analyses the market across varied regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the pharmaceutical filtration market
- Competitive Assessment: In-depth assessment of market shares, growth strategies and product offerings of leading players. A detailed analysis of the key industry players has been done to provide insights into their key strategies, product launches/ approvals, pipeline analysis, acquisitions, partnerships, agreements, collaborations, other recent developments, investment and funding activities, brand/product comparative analysis, and vendor valuation and financial metrics of the pharmaceutical filtration market.
Table of Contents
1 INTRODUCTION 54
1.1 STUDY OBJECTIVES 54
1.2 MARKET DEFINITION 54
1.3 STUDY SCOPE 55
1.3.1 INCLUSIONS & EXCLUSIONS 55
1.3.2 MARKET SEGMENTATION AND REGIONAL SCOPE 56
1.3.3 YEARS CONSIDERED 57
1.3.4 CURRENCY CONSIDERED 57
1.4 STAKEHOLDERS 57
1.5 SUMMARY OF CHANGES 58
2 RESEARCH METHODOLOGY 59
2.1 RESEARCH DATA 59
2.1.1 SECONDARY DATA 60
2.1.1.1 Key data from secondary sources 61
2.1.2 PRIMARY DATA 61
2.1.2.1 Key data from primary sources 63
2.1.2.2 Key industry insights 64
2.2 MARKET ESTIMATION METHODOLOGY 64
2.2.1 GLOBAL MARKET ESTIMATION 65
2.2.2 SEGMENTAL MARKET SIZE ESTIMATION 68
2.3 MARKET GROWTH RATE PROJECTIONS 69
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 71
2.5 RESEARCH ASSUMPTIONS 72
2.6 RESEARCH LIMITATIONS 73
2.7 RISK ANALYSIS 73
3 EXECUTIVE SUMMARY 74
4 PREMIUM INSIGHTS 78
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN PHARMACEUTICAL FILTRATION MARKET 78
4.2 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY END USER AND COUNTRY, 2023 79
4.3 PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2023 80
4.4 PHARMACEUTICAL FILTRATION MARKET, BY END USER, 2023 80
4.5 PHARMACEUTICAL FILTRATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 81
5 MARKET OVERVIEW 82
5.1 INTRODUCTION 82
5.2 MARKET DYNAMICS 82
5.2.1 DRIVERS 84
5.2.1.1 Growing pharmaceutical industry 84
5.2.1.2 Rising R&D spending in pharmaceutical and biotechnology industries 85
5.2.1.3 Increasing adoption of single-use technologies 86
5.2.1.4 Increasing purity requirement in pharmaceutical and biotechnology manufacturing 87
5.2.1.5 Adoption of continuous manufacturing process 87
5.2.2 RESTRAINTS 88
5.2.2.1 Membrane fouling and breakage issues 88
5.2.2.2 High capital investments required for new production facilities 88
5.2.2.3 Technological limitations 88
5.2.3 OPPORTUNITIES 89
5.2.3.1 Growth opportunities in emerging economies 89
5.2.3.2 Advances in nanofiber technology 90
5.2.3.3 Growing need for high-efficiency filters for vaccine production 90
5.2.4 CHALLENGES 90
5.2.4.1 Increased cost and reduced speed and yield of filters 90
5.2.4.2 Survival of small players and new entrants 91
5.2.4.3 Stringent regulatory compliance 91
5.3 TECHNOLOGY ANALYSIS 92
5.3.1 KEY TECHNOLOGIES 92
5.3.1.1 Microfiltration 92
5.3.1.2 Ultrafiltration 92
5.3.1.3 Nanofiltration 93
5.3.2 COMPLEMENTARY TECHNOLOGIES 93
5.3.2.1 Single-Use Technology 93
5.3.2.2 Electrospun Microfibers 93
5.3.2.3 Photocatalytic Filtration 94
5.3.3 ADJACENT TECHNOLOGIES 94
5.3.3.1 Chromatography 94
5.3.3.2 Centrifugation 95
5.3.3.3 Microfluidics 95
5.4 SUPPLY CHAIN ANALYSIS 95
5.5 VALUE CHAIN ANALYSIS 97
5.6 PRICING ANALYSIS 99
5.6.1 AVERAGE SELLING PRICE TREND OF KEY PRODUCTS,
BY KEY PLAYERS, 2021–2023 100
5.6.2 AVERAGE SELLING PRICE OF KEY PRODUCTS, BY REGION, 2023 101
5.7 ECOSYSTEM ANALYSIS 101
5.7.1 RAW MATERIAL VENDORS IN PHARMACEUTICAL FILTRATION MARKET 102
5.7.2 PRODUCT VENDORS IN PHARMACEUTICAL FILTRATION MARKET 102
5.7.3 END USERS IN PHARMACEUTICAL FILTRATION MARKET 103
5.7.4 REGULATORY BODIES IN PHARMACEUTICAL FILTRATION MARKET 104
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 104
5.9 PATENT ANALYSIS 105
5.9.1 PATENT METHODOLOGY 105
5.9.2 PATENTS FILED, BY DOCUMENT TYPE, 2014–2024 106
5.10 KEY CONFERENCES & EVENTS 107
5.11 REGULATORY LANDSCAPE 108
5.11.1 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS IN DIFFERENT REGIONS/COUNTRIES 108
5.11.2 REGULATORY FRAMEWORK 110
5.12 PORTER’S FIVE FORCES ANALYSIS 111
5.12.1 THREAT OF NEW ENTRANTS 112
5.12.2 THREAT OF SUBSTITUTES 112
5.12.3 BARGAINING POWER OF BUYERS 112
5.12.4 BARGAINING POWER OF SUPPLIERS 112
5.12.5 INTENSITY OF COMPETITIVE RIVALRY 113
5.13 KEY STAKEHOLDERS & BUYING CRITERIA 113
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 113
5.13.2 ROLE OF STAKEHOLDER IN BUYING PROCESS 113
5.13.3 BUYING CRITERIA FOR PHARMACEUTICAL FILTRATION MARKET 114
5.14 CASE STUDY ANALYSIS 115
5.14.1 COST SAVING/OPTIMIZATION 115
5.14.2 SUPPLY CHAIN SIMPLIFICATION 115
5.14.3 COST SAVING AND SYSTEM OPTIMIZATION 115
5.14.4 INTERMITTENT PREMATURE FILTER FOULING SOLVED 115
5.15 INVESTMENT/FUNDING SCENARIO 116
5.16 TRADE DATA ANALYSIS 117
5.17 IMPACT OF AI ON PHARMACEUTICAL FILTRATION MARKET 120
6 PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT 122
6.1 INTRODUCTION 123
6.2 CONSUMABLES 123
6.2.1 FILTERS 128
6.2.1.1 Membrane Filters 132
6.2.1.1.1 Polyethersulfone (PES) 135
6.2.1.1.1.1 Wide use of hydrophilic PES membranes in sterilizing applications to drive growth 135
6.2.1.1.2 Polyvinylidene difluoride (PVDF) 139
6.2.1.1.2.1 Nontoxic nature to increase demand for PVDF filters 139
6.2.1.1.3 Nylon 142
6.2.1.1.3.1 Increased endotoxin adsorption capacity of nylon filters to drive growth 142
6.2.1.1.4 Polytetrafluoroethylene (PTFE) 145
6.2.1.1.4.1 PTFE membrane filters offer retention of ratings as fine as 0.01μ 145
6.2.1.1.5 Mixed cellulose ester & cellulose acetate (MCE & CA) 148
6.2.1.1.5.1 Growing analytical and research applications to drive market 148
6.2.1.1.6 Polycarbonate track-etched (PCTE) 152
6.2.1.1.6.1 Wide use in cell biology and analytical testing applications 152
6.2.1.1.7 Other materials 155
6.2.1.2 Depth filters 158
6.2.1.2.1 Diatomaceous earth 161
6.2.1.2.1.1 Increased use in biotechnology industry for cell clarification 161
6.2.1.2.2 Cellulose 165
6.2.1.2.2.1 Cost-effectiveness of cellulose-based depth filters to drive growth 165
6.2.1.2.3 Activated carbon 168
6.2.1.2.3.1 Reliable and cost-effective activated carbon filters supporting pharmaceutical manufacturing operations 168
6.2.1.2.4 Perlite 171
6.2.1.2.4.1 Lower density of perlite provides more purity than diatomaceous earth 171
6.2.1.2.5 Other depth filter media 174
6.2.1.3 Air filters 177
6.2.1.4 Virus filters 180
6.2.1.5 Other filters 183
6.2.2 OTHER CONSUMABLES 187
6.2.2.1 FILTRATION ASSEMBLIES 190
6.2.2.1.1 Microfiltration assemblies 193
6.2.2.1.1.1 Growing demand for high-quality products to support segment growth 193
6.2.2.1.2 Ultrafiltration assemblies 197
6.2.2.1.2.1 Stringent regulatory requirements likely to support segment growth 197
6.2.2.1.3 Nanofiltration assemblies 200
6.2.2.1.3.1 Increasing demand for high-purity biopharmaceuticals to propel segment growth 200
6.2.2.1.4 Other filtration assemblies 204
6.2.3 FILTER HOLDERS 207
6.2.3.1 Filter holders provide structural support to membrane filters 207
6.2.4 FILTRATION ACCESSORIES 210
6.2.4.1 Increasing adoption of pharmaceutical filtration products to support growth 210
6.3 SYSTEMS 213
6.3.1 SINGLE-USE SYSTEMS 217
6.3.1.1 Reduced need for product validation and minimized cross-contamination risk to boost adoption 217
6.3.2 REUSABLE SYSTEMS 220
6.3.2.1 Reusable systems widely used for large-scale manufacturing 220
7 PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE 224
7.1 INTRODUCTION 225
7.2 MICROFILTRATION 225
7.2.1 INCREASED ADOPTION OF MICROFILTRATION TO PROPEL MARKET GROWTH 225
7.3 ULTRAFILTRATION 229
7.3.1 ADOPTION OF FINE FILTRATION TECHNIQUES
TO DRIVE GROWTH 229
7.4 NANOFILTRATION 232
7.4.1 RISING DEMAND IN BIOTECHNOLOGY INDUSTRY
TO SUPPORT MARKET GROWTH 232
7.5 OTHER TECHNIQUES 236
8 PHARMACEUTICAL FILTRATION MARKET, BY TYPE 240
8.1 INTRODUCTION 241
8.2 STERILE FILTRATION 241
8.2.1 ADVANTAGES OF STERILE FILTERS OVER NON-STERILE FILTERS TO DRIVE GROWTH 241
8.3 NON-STERILE FILTRATION 245
8.3.1 GROWTH IN PHARMA R&D ACTIVITIES TO PROMOTE MARKET GROWTH 245
9 PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION 248
9.1 INTRODUCTION 249
9.2 FINAL PRODUCT PROCESSING 249
9.2.1 ACTIVE PHARMACEUTICAL INGREDIENT (API) FILTRATION 253
9.2.1.1 Continuous requirement for API filtration 253
9.2.2 PROTEIN PURIFICATION 257
9.2.2.1 Recent advancements in protein therapeutic drugs 257
9.2.3 VACCINE AND ANTIBODY PROCESSING 260
9.2.3.1 Development of vaccines for viral diseases 260
9.2.4 FORMULATION AND FILLING SOLUTIONS 265
9.2.4.1 Demand for aseptic filling and bioburden reduction 265
9.2.5 VIRAL CLEARANCE 268
9.2.5.1 Growing development of therapeutic monoclonal antibodies 268
9.3 RAW MATERIAL FILTRATION 272
9.3.1 MEDIA BUFFER FILTRATION 275
9.3.1.1 Growth in manufacturing of biopharmaceuticals to drive market 275
9.3.2 PREFILTRATION 279
9.3.2.1 High demand due to membrane fouling issues 279
9.3.3 BIOBURDEN TESTING 282
9.3.3.1 Strict quality control of biopharmaceuticals to drive market 282
9.4 CELL SEPARATION 286
9.4.1 GROWTH IN PERSONALIZED MEDICINE TO PROPEL MARKET 286
9.5 WATER PURIFICATION 289
9.5.1 GROWTH IN GERIATRIC POPULATION TO DRIVE MARKET 289
9.6 AIR PURIFICATION 293
9.6.1 INCREASING ADOPTION OF GOOD MANUFACTURING PRACTICES TO DRIVE MARKET 293
10 PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION 297
10.1 INTRODUCTION 298
10.2 MANUFACTURING-SCALE OPERATION 298
10.2.1 GROWTH IN BIOLOGICS AND BIOSIMILAR MANUFACTURING TO DRIVE MARKET 298
10.3 PILOT-SCALE OPERATION 303
10.3.1 INCREASED OUTSOURCING TO DRIVE MARKET GROWTH 303
10.4 R&D-SCALE OPERATION 306
10.4.1 INCREASING INVESTMENTS IN R&D OF BIOLOGICS TO PROPEL GROWTH 306
11 PHARMACEUTICAL FILTRATION MARKET, BY END USER 310
11.1 INTRODUCTION 311
11.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES 311
11.2.1 GROWING BIOLOGICS PRODUCTION TO DRIVE DEMAND 311
11.3 CMOS & CROS 316
11.3.1 INCREASING OUTSOURCING OF R&D SERVICES TO SUPPORT MARKET GROWTH 316
11.4 ACADEMIC & RESEARCH INSTITUTES 319
11.4.1 GROWING PHARMA-ACADEMIA COLLABORATIONS TO DRIVE ADOPTION 319
12 PHARMACEUTICAL FILTRATION MARKET, BY REGION 323
12.1 INTRODUCTION 324
12.2 NORTH AMERICA 324
12.2.1 NORTH AMERICA: MACROECONOMIC ANALYSIS 325
12.2.2 US 333
12.2.2.1 US to dominate North American market during forecast period 333
12.2.3 CANADA 340
12.2.3.1 Growing government support for expanding biologics manufacturing facilities to support market 340
12.3 EUROPE 347
12.3.1 EUROPE: MACROECONOMIC ANALYSIS 347
12.3.2 GERMANY 354
12.3.2.1 Growing pharmaceutical R&D and manufacturing to drive market 354
12.3.3 UK 361
12.3.3.1 Growing awareness of quality of drugs increasing uptake of filtration products in drug discovery labs 361
12.3.4 FRANCE 367
12.3.4.1 Government investment in pharmaceutical industry to drive growth 367
12.3.5 ITALY 374
12.3.5.1 Investment in biotechnology R&D to boost market growth 374
12.3.6 SPAIN 381
12.3.6.1 Expansion of biomanufacturing facilities to support market 381
12.3.7 SWITZERLAND 388
12.3.7.1 Presence of key pharmaceutical and biopharmaceutical companies to support market 388
12.3.8 REST OF EUROPE 395
12.4 ASIA PACIFIC 402
12.4.1 ASIA PACIFIC: MACROECONOMIC ANALYSIS 404
12.4.2 CHINA 412
12.4.2.1 Improving drug development activities to drive market 412
12.4.3 JAPAN 418
12.4.3.1 Stringent regulatory guidelines to create need for advanced filtration products 418
12.4.4 INDIA 425
12.4.4.1 Favorable scenario for foreign direct investment to favor market growth 425
12.4.5 SOUTH KOREA 432
12.4.5.1 Increased export of drugs to support market growth 432
12.4.6 AUSTRALIA 439
12.4.6.1 Increasing demand for innovative filtration solutions to propel market 439
12.4.7 REST OF ASIA PACIFIC 445
12.5 LATIN AMERICA 452
12.5.1 LATIN AMERICA: MACROECONOMIC ANALYSIS 453
12.5.2 BRAZIL 460
12.5.2.1 Increased government investments in pharmaceutical R&D to drive market 460
12.5.3 MEXICO 466
12.5.3.1 Rising demand for chronic disease treatment to support market growth 466
12.5.4 REST OF LATIN AMERICA 472
12.6 MIDDLE EAST 478
12.6.1 MIDDLE EAST: MACROECONOMIC ANALYSIS 479
12.6.2 GCC COUNTRIES 486
12.6.3 SAUDI ARABIA 493
12.6.3.1 Growing healthcare expenditure to boost market growth 493
12.6.4 UAE 500
12.6.4.1 Adoption of more efficient and precise filtration processes to aid market growth 500
12.6.5 REST OF GCC COUNTRIES 506
12.6.6 REST OF MIDDLE EAST 512
12.7 AFRICA 519
12.7.1 AFRICA: MACROECONOMIC ANALYSIS 519
13 COMPETITIVE LANDSCAPE 527
13.1 INTRODUCTION 527
13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022−2024 527
13.3 REVENUE SHARE ANALYSIS, 2019–2023 529
13.4 MARKET SHARE ANALYSIS, 2023 529
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 531
13.5.1 STARS 532
13.5.2 EMERGING LEADERS 532
13.5.3 PERVASIVE PLAYERS 532
13.5.4 PARTICIPANTS 532
13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 534
13.5.5.1 Company footprint 534
13.5.5.2 Product footprint 535
13.5.5.3 Technique footprint 536
13.5.5.4 Application footprint 537
13.5.5.5 Region footprint 539
13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 540
13.6.1 PROGRESSIVE COMPANIES 540
13.6.2 RESPONSIVE COMPANIES 540
13.6.3 DYNAMIC COMPANIES 540
13.6.4 STARTING BLOCKS 540
13.7 COMPETITIVE BENCHMARKING OF STARTUPS/SMES, 2023 542
13.8 VALUATION AND FINANCIAL METRICS OF PHARMACEUTICAL FILTRATION VENDORS 544
13.9 BRAND/PRODUCT COMPARATIVE ANALYSIS 545
13.9.1 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY PRODUCT 545
13.10 COMPETITIVE SCENARIO 546
13.10.1 PRODUCT LAUNCHES 546
13.10.2 DEALS 547
13.10.3 EXPANSIONS 548
14 COMPANY PROFILES 549
14.1 KEY PLAYERS 549
14.1.1 DANAHER CORPORATION 549
14.1.1.1 Business overview 549
14.1.1.2 Products offered 550
14.1.1.3 Recent developments 556
14.1.1.3.1 Product launches 556
14.1.1.3.2 Deals 557
14.1.1.3.3 Expansions 557
14.1.1.4 MnM view 558
14.1.1.4.1 Key strengths 558
14.1.1.4.2 Strategic choices 558
14.1.1.4.3 Weaknesses and competitive threats 558
14.1.2 MERCK KGAA 559
14.1.2.1 Business overview 559
14.1.2.2 Products offered 560
14.1.2.3 Recent developments 565
14.1.2.3.1 Expansions 565
14.1.2.3.2 Other developments 566
14.1.2.4 MnM view 566
14.1.2.4.1 Key strengths 566
14.1.2.4.2 Strategic choices 566
14.1.2.4.3 Weaknesses and competitive threats 567
14.1.3 SARTORIUS AG 568
14.1.3.1 Business overview 568
14.1.3.2 Products offered 569
14.1.3.3 Recent developments 572
14.1.3.3.1 Product launches 572
14.1.3.3.2 Deals 572
14.1.3.3.3 Expansions 573
14.1.3.4 MnM view 573
14.1.3.4.1 Key strengths 573
14.1.3.4.2 Strategic choices 573
14.1.3.4.3 Weaknesses and competitive threats 574
14.1.4 3M COMPANY 575
14.1.4.1 Business overview 575
14.1.4.2 Products offered 576
14.1.4.3 Recent developments 579
14.1.4.3.1 Product launches 579
14.1.4.3.2 Deals 579
14.1.4.3.3 Other developments 580
14.1.4.4 MnM view 580
14.1.4.4.1 Key strengths 580
14.1.4.4.2 Strategic choices 580
14.1.4.4.3 Weaknesses and competitive threats 580
14.1.5 REPLIGEN CORPORATION 581
14.1.5.1 Business overview 581
14.1.5.2 Products offered 582
14.1.5.3 Recent developments 584
14.1.5.3.1 Product launches 584
14.1.5.3.2 Deals 584
14.1.5.4 MnM view 584
14.1.5.4.1 Key strengths 584
14.1.5.4.2 Strategic choices 585
14.1.5.4.3 Weaknesses and competitive threats 585
14.1.6 PARKER HANNIFIN CORPORATION 586
14.1.6.1 Business overview 586
14.1.6.2 Products offered 587
14.1.7 EATON CORPORATION PLC 589
14.1.7.1 Business overview 589
14.1.7.2 Products offered 591
14.1.7.3 Recent developments 592
14.1.7.3.1 Product launches 592
14.1.8 THERMO FISHER SCIENTIFIC, INC. 593
14.1.8.1 Business overview 593
14.1.8.2 Products offered 594
14.1.8.3 Recent developments 597
14.1.8.3.1 Expansions 597
14.1.9 DONALDSON COMPANY, INC. 599
14.1.9.1 Business overview 599
14.1.9.2 Products offered 600
14.1.9.3 Recent developments 601
14.1.9.3.1 Deals 601
14.1.9.3.2 Expansions 602
14.1.10 PORVAIR PLC 603
14.1.10.1 Business overview 603
14.1.10.2 Products offered 604
14.1.10.3 Recent developments 606
14.1.10.3.1 Product launches 606
14.1.11 ALFA LAVAL CORPORATE AB 607
14.1.11.1 Business overview 607
14.1.11.2 Products offered 608
14.1.11.3 Recent developments 609
14.1.11.3.1 Product launches 609
14.1.12 CORNING INCORPORATED 610
14.1.12.1 Business overview 610
14.1.12.2 Products offered 611
14.1.13 MANN+HUMMEL 614
14.1.13.1 Business overview 614
14.1.13.2 Products offered 615
14.1.13.3 Recent developments 616
14.1.13.3.1 Deals 616
14.1.14 SAINT-GOBAIN 617
14.1.14.1 Business overview 617
14.1.14.2 Products offered 618
14.1.14.3 Recent developments 618
14.1.14.3.1 Product launches 618
14.1.14.3.2 Expansions 619
14.1.15 STERIS PLC 620
14.1.15.1 Business overview 620
14.1.15.2 Products offered 621
14.2 OTHER PLAYERS 622
14.2.1 MEISSNER FILTRATION PRODUCTS, INC. 622
14.2.2 AMAZON FILTERS LTD. 624
14.2.3 GRAVER TECHNOLOGIES, LLC. 626
14.2.4 MMS AG 628
14.2.5 ERTELALSOP 629
14.2.6 KASAG SWISS AG 630
14.2.7 FREUDENBERG FILTRATION TECHNOLOGIES SE & CO. KG 631
14.2.8 COLE-PARMER INSTRUMENT COMPANY, LLC 632
14.2.9 FILTROX AG 633
14.2.10 MEMBRANE SOLUTIONS 634
15 APPENDIX 635
15.1 DISCUSSION GUIDE 635
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 641
15.3 CUSTOMIZATION OPTIONS 643
15.4 RELATED REPORTS 644
15.5 AUTHOR DETAILS 645
LIST OF TABLES
TABLE 1 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS 70
TABLE 2 PHARMACEUTICAL FILTRATION MARKET: IMPACT ANALYSIS 83
TABLE 3 LIST OF TOP BIOLOGICAL LICENSE APPLICATION APPROVALS, 2023 84
TABLE 4 PHARMACEUTICAL R&D SPENDING, BY COMPANY, 2023 (USD BILLION) 86
TABLE 5 AVERAGE SELLING PRICE TREND OF KEY PRODUCTS, BY KEY PLAYERS,
2021–2023 100
TABLE 6 AVERAGE SELLING PRICE OF KEY PRODUCTS, BY REGION, 2023
(PRICE RANGE IN USD) 101
TABLE 7 PHARMACEUTICAL FILTRATION MARKET: ROLE OF RAW MATERIAL VENDORS 102
TABLE 8 PHARMACEUTICAL FILTRATION MARKET: ROLE OF PRODUCT VENDORS 103
TABLE 9 PHARMACEUTICAL FILTRATION MARKET: ROLE OF END USERS 103
TABLE 10 PHARMACEUTICAL FILTRATION MARKET: ROLE OF REGULATORY BODIES 104
TABLE 11 PATENTS FILED, 2014–2024 106
TABLE 12 PHARMACEUTICAL FILTRATION MARKET: KEY CONFERENCES & EVENTS,
2025–2026 107
TABLE 13 PHARMACEUTICAL FILTRATION MARKET: PORTER’S FIVE FORCES ANALYSIS 111
TABLE 14 BUYING CRITERIA FOR PHARMACEUTICAL FILTRATION PRODUCTS, BY END USER 114
TABLE 15 IMPORT VALUE FOR HS CODE 8421 (TOP 20 COUNTRIES),
2019–2023 (USD THOUSAND) 117
TABLE 16 EXPORT VALUE FOR HS CODE 8421 (TOP 20 COUNTRIES),
2019–2023 (USD THOUSAND) 118
TABLE 17 IMPORT VOLUME FOR HS CODE 8421 FOR TOP 20 COUNTRIES,
2019–2023 (TONS) 119
TABLE 18 EXPORT VOLUME FOR HS CODE 8421 FOR TOP 20 COUNTRIES,
2019–2023 (TONS) 120
TABLE 19 GLOBAL PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 123
TABLE 20 GLOBAL PHARMACEUTICAL CONSUMABLES MARKET, BY REGION,
2022–2029 (USD MILLION) 124
TABLE 21 NORTH AMERICA: PHARMACEUTICAL CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 124
TABLE 22 EUROPE: PHARMACEUTICAL CONSUMABLES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 125
TABLE 23 ASIA PACIFIC: PHARMACEUTICAL CONSUMABLES MARKET, BY COUNTRY/
REGION, 2022–2029 (USD MILLION) 125
TABLE 24 LATIN AMERICA: PHARMACEUTICAL CONSUMABLES MARKET, BY COUNTRY/ REGION, 2022–2029 (USD MILLION) 126
TABLE 25 MIDDLE EAST: PHARMACEUTICAL CONSUMABLES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 126
TABLE 26 GCC COUNTRIES: PHARMACEUTICAL CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 126
TABLE 27 GLOBAL PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 127
TABLE 28 GLOBAL PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 127
TABLE 29 PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION) 128
TABLE 30 GLOBAL PHARMACEUTICAL FILTERS MARKET, BY REGION,
2022–2029 (USD MILLION) 128
TABLE 31 NORTH AMERICA: PHARMACEUTICAL FILTERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 129
TABLE 32 EUROPE: PHARMACEUTICAL FILTERS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 129
TABLE 33 ASIA PACIFIC: PHARMACEUTICAL FILTERS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 130
TABLE 34 LATIN AMERICA: PHARMACEUTICAL FILTERS MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 130
TABLE 35 MIDDLE EAST: PHARMACEUTICAL FILTERS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 130
TABLE 36 GCC COUNTRIES: PHARMACEUTICAL FILTERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 131
TABLE 37 GLOBAL PHARMACEUTICAL FILTERS MARKET, BY TYPE,
2022–2029 (USD MILLION) 131
TABLE 38 GLOBAL PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY REGION,
2022–2029 (USD MILLION) 132
TABLE 39 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 133
TABLE 40 EUROPE: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 133
TABLE 41 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTERS MARKET,
BY COUNTRY/REGION, 2022–2029 (USD MILLION) 134
TABLE 42 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTERS MARKET,
BY COUNTRY/REGION, 2022–2029 (USD MILLION) 134
TABLE 43 MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTERS MARKET,
BY COUNTRY/REGION, 2022–2029 (USD MILLION) 134
TABLE 44 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 135
TABLE 45 MEMBRANE FILTERS MARKET, BY MATERIAL, 2022–2029 (USD MILLION) 135
TABLE 46 GLOBAL PES MEMBRANE FILTERS MARKET, BY REGION,
2022–2029 (USD MILLION) 136
TABLE 47 NORTH AMERICA: PES MEMBRANE FILTERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 136
TABLE 48 EUROPE: PES MEMBRANE FILTERS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 137
TABLE 49 ASIA PACIFIC: PES MEMBRANE FILTERS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 137
TABLE 50 LATIN AMERICA: PES MEMBRANE FILTERS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 138
TABLE 51 MIDDLE EAST: PES MEMBRANE FILTERS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 138
TABLE 52 GCC COUNTRIES: PES MEMBRANE FILTERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 138
TABLE 53 GLOBAL PVDF MEMBRANE FILTERS MARKET, BY REGION,
2022–2029 (USD MILLION) 139
TABLE 54 NORTH AMERICA: PVDF MEMBRANE FILTERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 140
TABLE 55 EUROPE: PVDF MEMBRANE FILTERS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 140
TABLE 56 ASIA PACIFIC: PVDF MEMBRANE FILTERS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 141
TABLE 57 LATIN AMERICA: PVDF MEMBRANE FILTERS MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 141
TABLE 58 MIDDLE EAST: PVDF MEMBRANE FILTERS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 141
TABLE 59 GCC COUNTRIES: PVDF MEMBRANE FILTERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 142
TABLE 60 GLOBAL NYLON MEMBRANE FILTERS MARKET, BY REGION,
2022–2029 (USD MILLION) 142
TABLE 61 NORTH AMERICA: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 143
TABLE 62 EUROPE: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 143
TABLE 63 ASIA PACIFIC: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 144
TABLE 64 LATIN AMERICA: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 144
TABLE 65 MIDDLE EAST: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 144
TABLE 66 GCC COUNTRIES: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 145
TABLE 67 GLOBAL PTFE MEMBRANE FILTERS MARKET, BY REGION,
2022–2029 (USD MILLION) 145
TABLE 68 NORTH AMERICA: PTFE MEMBRANE FILTERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 146
TABLE 69 EUROPE: PTFE MEMBRANE FILTERS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 146
TABLE 70 ASIA PACIFIC: PTFE MEMBRANE FILTERS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 147
TABLE 71 LATIN AMERICA: PTFE MEMBRANE FILTERS MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 147
TABLE 72 MIDDLE EAST: PTFE MEMBRANE FILTERS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 147
TABLE 73 GCC COUNTRIES: PTFE MEMBRANE FILTERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 148
TABLE 74 GLOBAL MCE & CA MEMBRANE FILTERS MARKET, BY REGION,
2022–2029 (USD MILLION) 149
TABLE 75 NORTH AMERICA: MCE & CA MEMBRANE FILTERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 149
TABLE 76 EUROPE: MCE & CA MEMBRANE FILTERS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 150
TABLE 77 ASIA PACIFIC: MCE & CA MEMBRANE FILTERS MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 150
TABLE 78 LATIN AMERICA: MCE & CA MEMBRANE FILTERS MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 151
TABLE 79 MIDDLE EAST: MCE & CA MEMBRANE FILTERS MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 151
TABLE 80 GCC COUNTRIES: MCE & CA MEMBRANE FILTERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 151
TABLE 81 GLOBAL PCTE MEMBRANE FILTERS MARKET, BY REGION,
2022–2029 (USD MILLION) 152
TABLE 82 NORTH AMERICA: PCTE MEMBRANE FILTERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 152
TABLE 83 EUROPE: PCTE MEMBRANE FILTERS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 153
TABLE 84 ASIA PACIFIC: PCTE MEMBRANE FILTERS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 153
TABLE 85 LATIN AMERICA: PCTE MEMBRANE FILTERS MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 154
TABLE 86 MIDDLE EAST: PCTE MEMBRANE FILTERS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 154
TABLE 87 GCC COUNTRIES: PCTE MEMBRANE FILTERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 154
TABLE 88 GLOBAL OTHER MATERIAL MEMBRANE FILTERS MARKET, BY REGION,
2022–2029 (USD MILLION) 155
TABLE 89 NORTH AMERICA: OTHER MATERIAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 155
TABLE 90 EUROPE: OTHER MATERIAL MEMBRANE FILTERS MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 156
TABLE 91 ASIA PACIFIC: OTHER MATERIAL MEMBRANE FILTERS MARKET, BY COUNTRY/ REGION, 2022–2029 (USD MILLION) 156
TABLE 92 LATIN AMERICA: OTHER MATERIAL MEMBRANE FILTERS MARKET, BY COUNTRY/ REGION, 2022–2029 (USD MILLION) 157
TABLE 93 MIDDLE EAST: OTHER MATERIAL MEMBRANE FILTERS MARKET,
BY COUNTRY/REGION, 2022–2029 (USD MILLION) 157
TABLE 94 GCC COUNTRIES: OTHER MATERIAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 157
TABLE 95 GLOBAL DEPTH FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 158
TABLE 96 NORTH AMERICA: DEPTH FILTERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 159
TABLE 97 EUROPE: DEPTH FILTERS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 159
TABLE 98 ASIA PACIFIC: DEPTH FILTERS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 160
TABLE 99 LATIN AMERICA: DEPTH FILTERS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 160
TABLE 100 MIDDLE EAST: DEPTH FILTERS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 160
TABLE 101 GCC COUNTRIES: DEPTH FILTERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 161
TABLE 102 DEPTH FILTERS MARKET, BY TYPE OF MEDIA, 2022–2029 (USD MILLION) 161
TABLE 103 GLOBAL DIATOMACEOUS EARTH FILTERS MARKET, BY REGION,
2022–2029 (USD MILLION) 162
TABLE 104 NORTH AMERICA: DIATOMACEOUS EARTH FILTERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 162
TABLE 105 EUROPE: DIATOMACEOUS EARTH FILTERS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 163
TABLE 106 ASIA PACIFIC: DIATOMACEOUS EARTH FILTERS MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 163
TABLE 107 LATIN AMERICA: DIATOMACEOUS EARTH FILTERS MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 164
TABLE 108 MIDDLE EAST: DIATOMACEOUS EARTH FILTERS MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 164
TABLE 109 GCC COUNTRIES: DIATOMACEOUS EARTH FILTERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 164
TABLE 110 GLOBAL CELLULOSE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 165
TABLE 111 NORTH AMERICA: CELLULOSE FILTERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 165
TABLE 112 EUROPE: CELLULOSE FILTERS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 166
TABLE 113 ASIA PACIFIC: CELLULOSE FILTERS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 166
TABLE 114 LATIN AMERICA: CELLULOSE FILTERS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 167
TABLE 115 MIDDLE EAST: CELLULOSE FILTERS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 167
TABLE 116 GCC COUNTRIES: CELLULOSE FILTERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 167
TABLE 117 GLOBAL ACTIVATED CARBON FILTERS MARKET, BY REGION,
2022–2029 (USD MILLION) 168
TABLE 118 NORTH AMERICA: ACTIVATED CARBON FILTERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 168
TABLE 119 EUROPE: ACTIVATED CARBON FILTERS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 169
TABLE 120 ASIA PACIFIC: ACTIVATED CARBON FILTERS MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 169
TABLE 121 LATIN AMERICA: ACTIVATED CARBON FILTERS MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 170
TABLE 122 MIDDLE EAST: ACTIVATED CARBON FILTERS MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 170
TABLE 123 GCC COUNTRIES: ACTIVATED CARBON FILTERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 170
TABLE 124 GLOBAL PERLITE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 171
TABLE 125 NORTH AMERICA: PERLITE FILTERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 171
TABLE 126 EUROPE: PERLITE FILTERS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 172
TABLE 127 ASIA PACIFIC: PERLITE FILTERS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 172
TABLE 128 LATIN AMERICA: PERLITE FILTERS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 173
TABLE 129 MIDDLE EAST: PERLITE FILTERS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 173
TABLE 130 GCC COUNTRIES: PERLITE FILTERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 173
TABLE 131 GLOBAL OTHER DEPTH FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 174
TABLE 132 NORTH AMERICA: OTHER DEPTH FILTERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 174
TABLE 133 EUROPE: OTHER DEPTH FILTERS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 175
TABLE 134 ASIA PACIFIC: OTHER DEPTH FILTERS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 175
TABLE 135 LATIN AMERICA: OTHER DEPTH FILTERS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 176
TABLE 136 MIDDLE EAST: OTHER DEPTH FILTERS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 176
TABLE 137 GCC COUNTRIES: OTHER DEPTH FILTERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 176
TABLE 138 GLOBAL AIR FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 177
TABLE 139 NORTH AMERICA: AIR FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 178
TABLE 140 EUROPE: AIR FILTERS MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 178
TABLE 141 ASIA PACIFIC: AIR FILTERS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 179
TABLE 142 LATIN AMERICA: AIR FILTERS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 179
TABLE 143 MIDDLE EAST: AIR FILTERS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 179
TABLE 144 GCC COUNTRIES: AIR FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 180
TABLE 145 GLOBAL VIRUS FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 180
TABLE 146 NORTH AMERICA: VIRUS FILTERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 181
TABLE 147 EUROPE: VIRUS FILTERS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 181
TABLE 148 ASIA PACIFIC: VIRUS FILTERS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 182
TABLE 149 LATIN AMERICA: VIRUS FILTERS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 182
TABLE 150 MIDDLE EAST: VIRUS FILTERS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 183
TABLE 151 GCC COUNTRIES: VIRUS FILTERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 183
TABLE 152 GLOBAL OTHER PHARMACEUTICAL FILTERS MARKET, BY REGION,
2022–2029 (USD MILLION) 184
TABLE 153 NORTH AMERICA: OTHER PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 184
TABLE 154 EUROPE: OTHER PHARMACEUTICAL FILTERS MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 185
TABLE 155 ASIA PACIFIC: OTHER PHARMACEUTICAL FILTERS MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 185
TABLE 156 LATIN AMERICA: OTHER PHARMACEUTICAL FILTERS MARKET,
BY COUNTRY/REGION, 2022–2029 (USD MILLION) 186
TABLE 157 MIDDLE EAST: OTHER PHARMACEUTICAL FILTERS MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 186
TABLE 158 GCC COUNTRIES: OTHER PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 186
TABLE 159 GLOBAL OTHER CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION) 187
TABLE 160 NORTH AMERICA: OTHER CONSUMABLES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 187
TABLE 161 EUROPE: OTHER CONSUMABLES MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 188
TABLE 162 ASIA PACIFIC: OTHER CONSUMABLES MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 188
TABLE 163 LATIN AMERICA: OTHER CONSUMABLES MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 189
TABLE 164 MIDDLE EAST: OTHER CONSUMABLES MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 189
TABLE 165 GCC COUNTRIES: OTHER CONSUMABLES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 189
TABLE 166 OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION) 190
TABLE 167 GLOBAL FILTRATION ASSEMBLIES MARKET, BY REGION,
2022–2029 (USD MILLION) 190
TABLE 168 NORTH AMERICA: FILTRATION ASSEMBLIES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 191
TABLE 169 EUROPE: FILTRATION ASSEMBLIES MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 191
TABLE 170 ASIA PACIFIC: FILTRATION ASSEMBLIES MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 192
TABLE 171 LATIN AMERICA: FILTRATION ASSEMBLIES MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 192
TABLE 172 MIDDLE EAST: FILTRATION ASSEMBLIES MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 192
TABLE 173 GCC COUNTRIES: FILTRATION ASSEMBLIES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 193
TABLE 174 PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET, BY TYPE,
2022–2029 (USD MILLION) 193
TABLE 175 GLOBAL MICROFILTRATION ASSEMBLIES MARKET, BY REGION,
2022–2029 (USD MILLION) 194
TABLE 176 NORTH AMERICA: MICROFILTRATION ASSEMBLIES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 194
TABLE 177 EUROPE: MICROFILTRATION ASSEMBLIES MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 195
TABLE 178 ASIA PACIFIC: MICROFILTRATION ASSEMBLIES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 195
TABLE 179 LATIN AMERICA: MICROFILTRATION ASSEMBLIES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 196
TABLE 180 MIDDLE EAST: MICROFILTRATION ASSEMBLIES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 196
TABLE 181 GCC COUNTRIES: MICROFILTRATION ASSEMBLIES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 196
TABLE 182 GLOBAL ULTRAFILTRATION ASSEMBLIES MARKET, BY REGION,
2022–2029 (USD MILLION) 197
TABLE 183 NORTH AMERICA: ULTRAFILTRATION ASSEMBLIES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 198
TABLE 184 EUROPE: ULTRAFILTRATION ASSEMBLIES MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 198
TABLE 185 ASIA PACIFIC: ULTRAFILTRATION ASSEMBLIES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 199
TABLE 186 LATIN AMERICA: ULTRAFILTRATION ASSEMBLIES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 199
TABLE 187 MIDDLE EAST: ULTRAFILTRATION ASSEMBLIES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 199
TABLE 188 GCC COUNTRIES: ULTRAFILTRATION ASSEMBLIES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 200
TABLE 189 GLOBAL NANOFILTRATION ASSEMBLIES MARKET, BY REGION,
2022–2029 (USD MILLION) 201
TABLE 190 NORTH AMERICA: NANOFILTRATION ASSEMBLIES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 201
TABLE 191 EUROPE: NANOFILTRATION ASSEMBLIES MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 202
TABLE 192 ASIA PACIFIC: NANOFILTRATION ASSEMBLIES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 202
TABLE 193 LATIN AMERICA: NANOFILTRATION ASSEMBLIES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 203
TABLE 194 MIDDLE EAST: NANOFILTRATION ASSEMBLIES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 203
TABLE 195 GCC COUNTRIES: NANOFILTRATION ASSEMBLIES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 203
TABLE 196 GLOBAL OTHER FILTRATION ASSEMBLIES MARKET, BY REGION,
2022–2029 (USD MILLION) 204
TABLE 197 NORTH AMERICA: OTHER FILTRATION ASSEMBLIES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 204
TABLE 198 EUROPE: OTHER FILTRATION ASSEMBLIES MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 205
TABLE 199 ASIA PACIFIC: OTHER FILTRATION ASSEMBLIES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 205
TABLE 200 LATIN AMERICA: OTHER FILTRATION ASSEMBLIES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 206
TABLE 201 MIDDLE EAST: OTHER FILTRATION ASSEMBLIES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 206
TABLE 202 GCC COUNTRIES: OTHER FILTRATION ASSEMBLIES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 206
TABLE 203 GLOBAL FILTER HOLDERS MARKET, BY REGION, 2022–2029 (USD MILLION) 207
TABLE 204 NORTH AMERICA: FILTER HOLDERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 207
TABLE 205 EUROPE: FILTER HOLDERS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 208
TABLE 206 ASIA PACIFIC: FILTER HOLDERS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 208
TABLE 207 LATIN AMERICA: FILTER HOLDERS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 209
TABLE 208 MIDDLE EAST: FILTER HOLDERS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 209
TABLE 209 GCC COUNTRIES: FILTER HOLDERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 209
TABLE 210 GLOBAL FILTER ACCESSORIES MARKET, BY REGION, 2022–2029 (USD MILLION) 210
TABLE 211 NORTH AMERICA: FILTER ACCESSORIES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 210
TABLE 212 EUROPE: FILTER ACCESSORIES MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 211
TABLE 213 ASIA PACIFIC: FILTER ACCESSORIES MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 211
TABLE 214 LATIN AMERICA: FILTER ACCESSORIES MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 212
TABLE 215 MIDDLE EAST: FILTER ACCESSORIES MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 212
TABLE 216 GCC COUNTRIES: FILTER ACCESSORIES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 212
TABLE 217 GLOBAL FILTRATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION) 213
TABLE 218 NORTH AMERICA: FILTRATION SYSTEMS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 213
TABLE 219 EUROPE: FILTRATION SYSTEMS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 214
TABLE 220 ASIA PACIFIC: FILTRATION SYSTEMS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 214
TABLE 221 LATIN AMERICA: FILTRATION SYSTEMS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 215
TABLE 222 MIDDLE EAST: FILTRATION SYSTEMS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 215
TABLE 223 GCC COUNTRIES: FILTRATION SYSTEMS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 215
TABLE 224 GLOBAL PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 216
TABLE 225 GLOBAL PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 216
TABLE 226 GLOBAL FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 216
TABLE 227 GLOBAL SINGLE-USE FILTRATION SYSTEMS MARKET, BY REGION,
2022–2029 (USD MILLION) 217
TABLE 228 NORTH AMERICA: SINGLE-USE FILTRATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 218
TABLE 229 EUROPE: SINGLE-USE FILTRATION SYSTEMS MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 218
TABLE 230 ASIA PACIFIC: SINGLE-USE FILTRATION SYSTEMS MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 219
TABLE 231 LATIN AMERICA: SINGLE-USE FILTRATION SYSTEMS MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 219
TABLE 232 MIDDLE EAST: SINGLE-USE FILTRATION SYSTEMS MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 219
TABLE 233 GCC COUNTRIES: SINGLE-USE FILTRATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 220
TABLE 234 GLOBAL REUSABLE SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION) 220
TABLE 235 NORTH AMERICA: REUSABLE SYSTEMS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 221
TABLE 236 EUROPE: REUSABLE SYSTEMS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 221
TABLE 237 ASIA PACIFIC: REUSABLE SYSTEMS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 222
TABLE 238 LATIN AMERICA: REUSABLE SYSTEMS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 222
TABLE 239 MIDDLE EAST: REUSABLE SYSTEMS MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 223
TABLE 240 GCC COUNTRIES: REUSABLE SYSTEMS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 223
TABLE 241 GLOBAL PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 225
TABLE 242 GLOBAL MICROFILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION) 226
TABLE 243 NORTH AMERICA: MICROFILTRATION MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 226
TABLE 244 EUROPE: MICROFILTRATION MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 227
TABLE 245 ASIA PACIFIC: MICROFILTRATION MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 227
TABLE 246 LATIN AMERICA: MICROFILTRATION MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 228
TABLE 247 MIDDLE EAST: MICROFILTRATION MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 228
TABLE 248 GCC COUNTRIES: MICROFILTRATION MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 228
TABLE 249 GLOBAL ULTRAFILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION) 229
TABLE 250 NORTH AMERICA: ULTRAFILTRATION MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 230
TABLE 251 EUROPE: ULTRAFILTRATION MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 230
TABLE 252 ASIA PACIFIC: ULTRAFILTRATION MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 231
TABLE 253 LATIN AMERICA: ULTRAFILTRATION MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 231
TABLE 254 MIDDLE EAST: ULTRAFILTRATION MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 231
TABLE 255 GCC COUNTRIES: ULTRAFILTRATION MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 232
TABLE 256 GLOBAL NANOFILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION) 233
TABLE 257 NORTH AMERICA: NANOFILTRATION MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 233
TABLE 258 EUROPE: NANOFILTRATION MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 234
TABLE 259 ASIA PACIFIC: NANOFILTRATION MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 234
TABLE 260 LATIN AMERICA: NANOFILTRATION MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 235
TABLE 261 MIDDLE EAST: NANOFILTRATION MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 235
TABLE 262 GCC COUNTRIES: NANOFILTRATION MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 235
TABLE 263 GLOBAL OTHER FILTRATION TECHNIQUES MARKET, BY REGION,
2022–2029 (USD MILLION) 236
TABLE 264 NORTH AMERICA: OTHER FILTRATION TECHNIQUES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 237
TABLE 265 EUROPE: OTHER FILTRATION TECHNIQUES MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 237
TABLE 266 ASIA PACIFIC: OTHER FILTRATION TECHNIQUES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 238
TABLE 267 LATIN AMERICA: OTHER FILTRATION TECHNIQUES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 238
TABLE 268 MIDDLE EAST: OTHER FILTRATION TECHNIQUES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 239
TABLE 269 GCC COUNTRIES: OTHER FILTRATION TECHNIQUES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 239
TABLE 270 GLOBAL PHARMACEUTICAL FILTRATION MARKET, BY TYPE,
2022–2029 (USD MILLION) 241
TABLE 271 GLOBAL STERILE FILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION) 242
TABLE 272 NORTH AMERICA: STERILE FILTRATION MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 242
TABLE 273 EUROPE: STERILE FILTRATION MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 243
TABLE 274 ASIA PACIFIC: STERILE FILTRATION MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 243
TABLE 275 LATIN AMERICA: STERILE FILTRATION MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 244
TABLE 276 MIDDLE EAST: STERILE FILTRATION MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 244
TABLE 277 GCC COUNTRIES: STERILE FILTRATION MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 244
TABLE 278 GLOBAL NON-STERILE FILTRATION MARKET, BY REGION,
2022–2029 (USD MILLION) 245
TABLE 279 NORTH AMERICA: NON-STERILE FILTRATION MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 245
TABLE 280 EUROPE: NON-STERILE FILTRATION MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 246
TABLE 281 ASIA PACIFIC: NON-STERILE FILTRATION MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 246
TABLE 282 LATIN AMERICA: NON-STERILE FILTRATION MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 247
TABLE 283 MIDDLE EAST: NON-STERILE FILTRATION MARKET, BY COUNTRY/REGION,
2022–2029 (USD MILLION) 247
TABLE 284 GCC COUNTRIES: NON-STERILE FILTRATION MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 247
TABLE 285 PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 249
TABLE 286 PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING,
BY REGION, 2022–2029 (USD MILLION) 250
TABLE 287 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2022–2029 (USD MILLION) 250
TABLE 288 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 251
TABLE 289 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 251
TABLE 290 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 252
TABLE 291 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 252
TABLE 292 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2022–2029 (USD MILLION) 252
TABLE 293 PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING,
BY TYPE, 2022–2029 (USD MILLION) 253
TABLE 294 ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY REGION,
2022–2029 (USD MILLION) 254
TABLE 295 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 254
TABLE 296 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET,
BY COUNTRY/REGION, 2022–2029 (USD MILLION) 255
TABLE 297 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET,
BY COUNTRY/REGION, 2022–2029 (USD MILLION) 255
TABLE 298 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET,
BY COUNTRY/REGION, 2022–2029 (USD MILLION) 256
TABLE 299 MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET,
BY COUNTRY/REGION, 2022–2029 (USD MILLION) 256
TABLE 300 GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 256
TABLE 301 PHARMACEUTICAL FILTRATION MARKET FOR PROTEIN PURIFICATION, BY REGION, 2022–2029 (USD MILLION) 257
TABLE 302 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR PROTEIN PURIFICATION, BY COUNTRY, 2022–2029 (USD MILLION) 258
TABLE 303 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR PROTEIN PURIFICATION,
BY COUNTRY/REGION, 2022–2029 (USD MILLION) 258
TABLE 304 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR PROTEIN PURIFICATION, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 259
TABLE 305 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR PROTEIN PURIFICATION, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 259
TABLE 306 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET FOR PROTEIN PURIFICATION, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 260
TABLE 307 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET FOR PROTEIN PURIFICATION, BY COUNTRY, 2022–2029 (USD MILLION) 260
TABLE 308 PHARMACEUTICAL FILTRATION MARKET FOR VACCINE AND ANTIBODY PROCESSING, BY REGION, 2022–2029 (USD MILLION) 262
TABLE 309 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR VACCINE AND ANTIBODY PROCESSING, BY COUNTRY, 2022–2029 (USD MILLION) 262
TABLE 310 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR VACCINE AND ANTIBODY PROCESSING, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 263
TABLE 311 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR VACCINE AND ANTIBODY PROCESSING, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 263
TABLE 312 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR VACCINE AND ANTIBODY PROCESSING, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 264
TABLE 313 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET FOR VACCINE AND ANTIBODY PROCESSING, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 264
TABLE 314 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET FOR VACCINE AND ANTIBODY PROCESSING, BY COUNTRY, 2022–2029 (USD MILLION) 264
TABLE 315 PHARMACEUTICAL FILTRATION MARKET FOR FORMULATION AND FILLING SOLUTIONS, BY REGION, 2022–2029 (USD MILLION) 265
TABLE 316 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR FORMULATION AND FILLING SOLUTIONS, BY COUNTRY, 2022–2029 (USD MILLION) 266
TABLE 317 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR FORMULATION AND FILLING SOLUTIONS, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 266
TABLE 318 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR FORMULATION AND FILLING SOLUTIONS, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 267
TABLE 319 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR FORMULATION AND FILLING SOLUTIONS, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 267
TABLE 320 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET FOR FORMULATION AND FILLING SOLUTIONS, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 268
TABLE 321 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET FOR FORMULATION AND FILLING SOLUTIONS, BY COUNTRY, 2022–2029 (USD MILLION) 268
TABLE 322 PHARMACEUTICAL FILTRATION MARKET FOR VIRAL CLEARANCE, BY REGION, 2022–2029 (USD MILLION) 269
TABLE 323 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR VIRAL CLEARANCE, BY COUNTRY, 2022–2029 (USD MILLION) 269
TABLE 324 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR VIRAL CLEARANCE,
BY COUNTRY/REGION, 2022–2029 (USD MILLION) 270
TABLE 325 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR VIRAL CLEARANCE,
BY COUNTRY/REGION, 2022–2029 (USD MILLION) 270
TABLE 326 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR VIRAL CLEARANCE, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 271
TABLE 327 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET FOR VIRAL CLEARANCE,
BY COUNTRY/REGION, 2022–2029 (USD MILLION) 271
TABLE 328 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET FOR VIRAL CLEARANCE, BY COUNTRY, 2022–2029 (USD MILLION) 271
TABLE 329 PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION,
BY REGION, 2022–2029 (USD MILLION) 272
TABLE 330 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY, 2022–2029 (USD MILLION) 272
TABLE 331 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 273
TABLE 332 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 273
TABLE 333 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 274
TABLE 334 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 274
TABLE 335 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY, 2022–2029 (USD MILLION) 274
TABLE 336 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 275
TABLE 337 PHARMACEUTICAL FILTRATION MARKET FOR MEDIA BUFFER FILTRATION,
BY REGION, 2022–2029 (USD MILLION) 276
TABLE 338 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR MEDIA BUFFER FILTRATION, BY COUNTRY, 2022–2029 (USD MILLION) 276
TABLE 339 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR MEDIA BUFFER FILTRATION, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 277
TABLE 340 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR MEDIA BUFFER FILTRATION, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 277
TABLE 341 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR MEDIA BUFFER FILTRATION, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 278
TABLE 342 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET FOR MEDIA BUFFER FILTRATION, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 278
TABLE 343 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET FOR MEDIA BUFFER FILTRATION, BY COUNTRY, 2022–2029 (USD MILLION) 278
TABLE 344 PHARMACEUTICAL FILTRATION MARKET FOR PREFILTRATION, BY REGION,
2022–2029 (USD MILLION) 279
TABLE 345 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR PREFILTRATION,
BY COUNTRY, 2022–2029 (USD MILLION) 280
TABLE 346 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR PREFILTRATION,
BY COUNTRY/REGION, 2022–2029 (USD MILLION) 280
TABLE 347 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR PREFILTRATION,
BY COUNTRY/REGION, 2022–2029 (USD MILLION) 281
TABLE 348 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR PREFILTRATION,
BY COUNTRY/REGION, 2022–2029 (USD MILLION) 281
TABLE 349 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET FOR PREFILTRATION,
BY COUNTRY/REGION, 2022–2029 (USD MILLION) 282
TABLE 350 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET FOR PREFILTRATION,
BY COUNTRY, 2022–2029 (USD MILLION) 282
TABLE 351 PHARMACEUTICAL FILTRATION MARKET FOR BIOBURDEN TESTING, BY REGION, 2022–2029 (USD MILLION) 283
TABLE 352 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR BIOBURDEN TESTING, BY COUNTRY, 2022–2029 (USD MILLION) 283
TABLE 353 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR BIOBURDEN TESTING,
BY COUNTRY/REGION, 2022–2029 (USD MILLION) 284
TABLE 354 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR BIOBURDEN TESTING, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 284
TABLE 355 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR BIOBURDEN TESTING, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 285
TABLE 356 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET FOR BIOBURDEN TESTING, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 285
TABLE 357 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET FOR BIOBURDEN TESTING, BY COUNTRY, 2022–2029 (USD MILLION) 285
TABLE 358 PHARMACEUTICAL FILTRATION MARKET FOR CELL SEPARATION, BY REGION, 2022–2029 (USD MILLION) 286
TABLE 359 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR CELL SEPARATION, BY COUNTRY, 2022–2029 (USD MILLION) 287
TABLE 360 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR CELL SEPARATION,
BY COUNTRY/REGION, 2022–2029 (USD MILLION) 287
TABLE 361 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR CELL SEPARATION,
BY COUNTRY/REGION, 2022–2029 (USD MILLION) 288
TABLE 362 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR CELL SEPARATION, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 288
TABLE 363 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET FOR CELL SEPARATION,
BY COUNTRY/REGION, 2022–2029 (USD MILLION) 289
TABLE 364 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET FOR CELL SEPARATION, BY COUNTRY, 2022–2029 (USD MILLION) 289
TABLE 365 PHARMACEUTICAL FILTRATION MARKET FOR WATER PURIFICATION, BY REGION, 2022–2029 (USD MILLION) 290
TABLE 366 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR WATER PURIFICATION, BY COUNTRY, 2022–2029 (USD MILLION) 290
TABLE 367 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR WATER PURIFICATION, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 291
TABLE 368 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR WATER PURIFICATION, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 291
TABLE 369 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR WATER PURIFICATION, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 292
TABLE 370 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET FOR WATER PURIFICATION, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 292
TABLE 371 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET FOR WATER PURIFICATION, BY COUNTRY, 2022–2029 (USD MILLION) 292
TABLE 372 PHARMACEUTICAL FILTRATION MARKET FOR AIR PURIFICATION, BY REGION, 2022–2029 (USD MILLION) 293
TABLE 373 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR AIR PURIFICATION, BY COUNTRY, 2022–2029 (USD MILLION) 294
TABLE 374 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR AIR PURIFICATION,
BY COUNTRY/REGION, 2022–2029 (USD MILLION) 294
TABLE 375 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR AIR PURIFICATION,
BY COUNTRY/REGION, 2022–2029 (USD MILLION) 295
TABLE 376 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR AIR PURIFICATION, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 295
TABLE 377 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET FOR AIR PURIFICATION,
BY COUNTRY/REGION, 2022–2029 (USD MILLION) 296
TABLE 378 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET FOR AIR PURIFICATION, BY COUNTRY, 2022–2029 (USD MILLION) 296
TABLE 379 GLOBAL PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION,
2022–2029 (USD MILLION) 298
TABLE 380 LIST OF FDA-APPROVED BIOSIMILAR PRODUCTS, 2022–2024 299
TABLE 381 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR MANUFACTURING-SCALE OPERATION, BY REGION, 2022–2029 (USD MILLION) 300
TABLE 382 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR MANUFACTURING-SCALE OPERATION, BY COUNTRY, 2022–2029 (USD MILLION) 300
TABLE 383 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR MANUFACTURING-SCALE OPERATION, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 301
TABLE 384 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR MANUFACTURING-SCALE OPERATION, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 301
TABLE 385 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR MANUFACTURING-SCALE OPERATION, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 302
TABLE 386 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET FOR MANUFACTURING-SCALE OPERATION, BY COUNTRY, 2022–2029 (USD MILLION) 302
TABLE 387 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET FOR MANUFACTURING-SCALE OPERATION, BY COUNTRY, 2022–2029 (USD MILLION) 302
TABLE 388 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR PILOT-SCALE OPERATION,
BY REGION, 2022–2029 (USD MILLION) 303
TABLE 389 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR PILOT-SCALE OPERATION, BY COUNTRY, 2022–2029 (USD MILLION) 304
TABLE 390 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR PILOT-SCALE OPERATION, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 304
TABLE 391 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR PILOT-SCALE OPERATION, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 305
TABLE 392 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR PILOT-SCALE OPERATION, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 305
TABLE 393 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET FOR PILOT-SCALE OPERATION, BY COUNTRY, 2022–2029 (USD MILLION) 306
TABLE 394 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET FOR PILOT-SCALE OPERATION, BY COUNTRY, 2022–2029 (USD MILLION) 306
TABLE 395 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR R&D-SCALE OPERATION,
BY REGION, 2022–2029 (USD MILLION) 307
TABLE 396 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR R&D-SCALE OPERATION, BY COUNTRY, 2022–2029 (USD MILLION) 307
TABLE 397 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR R&D-SCALE OPERATION,
BY COUNTRY/REGION, 2022–2029 (USD MILLION) 308
TABLE 398 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR R&D-SCALE OPERATION, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 308
TABLE 399 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR R&D-SCALE OPERATION, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 309
TABLE 400 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET FOR R&D-SCALE OPERATION, BY COUNTRY, 2022–2029 (USD MILLION) 309
TABLE 401 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET FOR R&D-SCALE OPERATION, BY COUNTRY, 2022–2029 (USD MILLION) 309
TABLE 402 PHARMACEUTICAL FILTRATION MARKET, BY END USER,
2022–2029 (USD MILLION) 311
TABLE 403 PHARMACEUTICAL FILTRATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION) 313
TABLE 404 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 313
TABLE 405 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 314
TABLE 406 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 314
TABLE 407 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 315
TABLE 408 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 315
TABLE 409 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 315
TABLE 410 PHARMACEUTICAL FILTRATION MARKET FOR CMOS & CROS, BY REGION,
2022–2029 (USD MILLION) 316
TABLE 411 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR CMOS & CROS,
BY COUNTRY, 2022–2029 (USD MILLION) 317
TABLE 412 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR CMOS & CROS,
BY COUNTRY/REGION, 2022–2029 (USD MILLION) 317
TABLE 413 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR CMOS & CROS,
BY COUNTRY/REGION, 2022–2029 (USD MILLION) 318
TABLE 414 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR CMOS & CROS,
BY COUNTRY/REGION, 2022–2029 (USD MILLION) 318
TABLE 415 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET FOR CMOS & CROS,
BY COUNTRY/REGION, 2022–2029 (USD MILLION) 319
TABLE 416 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET FOR CMOS & CROS,
BY COUNTRY, 2022–2029 (USD MILLION) 319
TABLE 417 PHARMACEUTICAL FILTRATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION) 320
TABLE 418 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 320
TABLE 419 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 321
TABLE 420 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 321
TABLE 421 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 322
TABLE 422 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 322
TABLE 423 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 322
TABLE 424 PHARMACEUTICAL FILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION) 324
TABLE 425 MACROECONOMIC OUTLOOK FOR PHARMACEUTICAL FILTRATION MARKET IN NORTH AMERICA 325
TABLE 426 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 327
TABLE 427 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 327
TABLE 428 NORTH AMERICA: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 327
TABLE 429 NORTH AMERICA: PHARMACEUTICAL FILTERS MARKET, BY TYPE,
2022–2029 (USD MILLION) 328
TABLE 430 NORTH AMERICA: MEMBRANE FILTERS MARKET, BY MATERIAL,
2022–2029 (USD MILLION) 328
TABLE 431 NORTH AMERICA: DEPTH FILTERS MARKET, BY TYPE OF MEDIA,
2022–2029 (USD MILLION) 329
TABLE 432 NORTH AMERICA: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 329
TABLE 433 NORTH AMERICA: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET, BY TYPE, 2022–2029 (USD MILLION) 330
TABLE 434 NORTH AMERICA: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 330
TABLE 435 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 330
TABLE 436 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE,
2022–2029 (USD MILLION) 331
TABLE 437 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 331
TABLE 438 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 332
TABLE 439 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 332
TABLE 440 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 333
TABLE 441 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY END USER,
2022–2029 (USD MILLION) 333
TABLE 442 US: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 334
TABLE 443 US: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION) 335
TABLE 444 US: PHARMACEUTICAL FILTRATION FILTERS MARKET, BY TYPE,
2022–2029 (USD MILLION) 335
TABLE 445 US: MEMBRANE FILTERS MARKET, BY MATERIAL, 2022–2029 (USD MILLION) 336
TABLE 446 US: DEPTH FILTERS MARKET, BY TYPE OF MEDIA, 2022–2029 (USD MILLION) 336
TABLE 447 US: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 337
TABLE 448 US: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET, BY TYPE,
2022–2029 (USD MILLION) 337
TABLE 449 US: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION) 337
TABLE 450 US: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 338
TABLE 451 US: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION) 338
TABLE 452 US: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 338
TABLE 453 US: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING,
BY TYPE, 2022–2029 (USD MILLION) 339
TABLE 454 US: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION,
BY TYPE, 2022–2029 (USD MILLION) 339
TABLE 455 US: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION,
2022–2029 (USD MILLION) 340
TABLE 456 US: PHARMACEUTICAL FILTRATION MARKET, BY END USER,
2022–2029 (USD MILLION) 340
TABLE 457 CANADA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 341
TABLE 458 CANADA: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION) 341
TABLE 459 CANADA: PHARMACEUTICAL FILTERS MARKET, BY TYPE,
2022–2029 (USD MILLION) 341
TABLE 460 CANADA: MEMBRANE FILTERS MARKET, BY MATERIAL,
2022–2029 (USD MILLION) 342
TABLE 461 CANADA: DEPTH FILTERS MARKET, BY TYPE OF MEDIA,
2022–2029 (USD MILLION) 342
TABLE 462 CANADA: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 343
TABLE 463 CANADA: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET, BY TYPE,
2022–2029 (USD MILLION) 343
TABLE 464 CANADA: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION) 343
TABLE 465 CANADA: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 344
TABLE 466 CANADA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE,
2022–2029 (USD MILLION) 344
TABLE 467 CANADA: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 345
TABLE 468 CANADA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 345
TABLE 469 CANADA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 346
TABLE 470 CANADA: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 346
TABLE 471 CANADA: PHARMACEUTICAL FILTRATION MARKET, BY END USER,
2022–2029 (USD MILLION) 346
TABLE 472 MACROECONOMIC OUTLOOK FOR PHARMACEUTICAL FILTRATION MARKET
IN EUROPE 348
TABLE 473 EUROPE: PHARMACEUTICAL FILTRATION MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 348
TABLE 474 EUROPE: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 349
TABLE 475 EUROPE: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION) 349
TABLE 476 EUROPE: PHARMACEUTICAL FILTERS MARKET, BY TYPE,
2022–2029 (USD MILLION) 349
TABLE 477 EUROPE: MEMBRANE FILTERS MARKET, BY MATERIAL,
2022–2029 (USD MILLION) 350
TABLE 478 EUROPE: DEPTH FILTERS MARKET, BY TYPE OF MEDIA,
2022–2029 (USD MILLION) 350
TABLE 479 EUROPE: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 351
TABLE 480 EUROPE: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET, BY TYPE,
2022–2029 (USD MILLION) 351
TABLE 481 EUROPE: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION) 351
TABLE 482 EUROPE: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 352
TABLE 483 EUROPE: PHARMACEUTICAL FILTRATION MARKET, BY TYPE,
2022–2029 (USD MILLION) 352
TABLE 484 EUROPE: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 352
TABLE 485 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 353
TABLE 486 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 353
TABLE 487 EUROPE: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 354
TABLE 488 EUROPE: PHARMACEUTICAL FILTRATION MARKET, BY END USER,
2022–2029 (USD MILLION) 354
TABLE 489 GERMANY: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 355
TABLE 490 GERMANY: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 355
TABLE 491 GERMANY: PHARMACEUTICAL FILTERS MARKET, BY TYPE,
2022–2029 (USD MILLION) 356
TABLE 492 GERMANY: MEMBRANE FILTERS MARKET, BY MATERIAL,
2022–2029 (USD MILLION) 356
TABLE 493 GERMANY: DEPTH FILTERS MARKET, BY TYPE OF MEDIA,
2022–2029 (USD MILLION) 357
TABLE 494 GERMANY: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 357
TABLE 495 GERMANY: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET, BY TYPE,
2022–2029 (USD MILLION) 357
TABLE 496 GERMANY: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION) 358
TABLE 497 GERMANY: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 358
TABLE 498 GERMANY: PHARMACEUTICAL FILTRATION MARKET, BY TYPE,
2022–2029 (USD MILLION) 358
TABLE 499 GERMANY: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 359
TABLE 500 GERMANY: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 359
TABLE 501 GERMANY: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 360
TABLE 502 GERMANY: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 360
TABLE 503 GERMANY: PHARMACEUTICAL FILTRATION MARKET, BY END USER,
2022–2029 (USD MILLION) 360
TABLE 504 UK: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 361
TABLE 505 UK: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION) 361
TABLE 506 UK: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 362
TABLE 507 UK: MEMBRANE FILTERS MARKET, BY MATERIAL, 2022–2029 (USD MILLION) 362
TABLE 508 UK: DEPTH FILTERS MARKET, BY TYPE OF MEDIA, 2022–2029 (USD MILLION) 363
TABLE 509 UK: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 363
TABLE 510 UK: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET, BY TYPE,
2022–2029 (USD MILLION) 364
TABLE 511 UK: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION) 364
TABLE 512 UK: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 364
TABLE 513 UK: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION) 365
TABLE 514 UK: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 365
TABLE 515 UK: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 366
TABLE 516 UK: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION,
BY TYPE, 2022–2029 (USD MILLION) 366
TABLE 517 UK: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION,
2022–2029 (USD MILLION) 367
TABLE 518 UK: PHARMACEUTICAL FILTRATION MARKET, BY END USER,
2022–2029 (USD MILLION) 367
TABLE 519 FRANCE: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 368
TABLE 520 FRANCE: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION) 369
TABLE 521 FRANCE: PHARMACEUTICAL FILTERS MARKET, BY TYPE,
2022–2029 (USD MILLION) 369
TABLE 522 FRANCE: MEMBRANE FILTERS MARKET, BY MATERIAL, 2022–2029 (USD MILLION) 370
TABLE 523 FRANCE: DEPTH FILTERS MARKET, BY TYPE OF MEDIA,
2022–2029 (USD MILLION) 370
TABLE 524 FRANCE: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 371
TABLE 525 FRANCE: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 371
TABLE 526 FRANCE: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION) 371
TABLE 527 FRANCE: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 372
TABLE 528 FRANCE: PHARMACEUTICAL FILTRATION MARKET, BY TYPE,
2022–2029 (USD MILLION) 372
TABLE 529 FRANCE: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 372
TABLE 530 FRANCE: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 373
TABLE 531 FRANCE: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 373
TABLE 532 FRANCE: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 374
TABLE 533 FRANCE: PHARMACEUTICAL FILTRATION MARKET, BY END USER,
2022–2029 (USD MILLION) 374
TABLE 534 ITALY: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 375
TABLE 535 ITALY: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION) 375
TABLE 536 ITALY: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 376
TABLE 537 ITALY: MEMBRANE FILTERS MARKET, BY MATERIAL, 2022–2029 (USD MILLION) 376
TABLE 538 ITALY: DEPTH FILTERS MARKET, BY TYPE OF MEDIA, 2022–2029 (USD MILLION) 377
TABLE 539 ITALY: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 377
TABLE 540 ITALY: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET, BY TYPE,
2022–2029 (USD MILLION) 378
TABLE 541 ITALY: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION) 378
TABLE 542 ITALY: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 378
TABLE 543 ITALY: PHARMACEUTICAL FILTRATION MARKET, BY TYPE,
2022–2029 (USD MILLION) 379
TABLE 544 ITALY: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 379
TABLE 545 ITALY: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 380
TABLE 546 ITALY: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 380
TABLE 547 ITALY: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION,
2022–2029 (USD MILLION) 381
TABLE 548 ITALY: PHARMACEUTICAL FILTRATION MARKET, BY END USER,
2022–2029 (USD MILLION) 381
TABLE 549 SPAIN: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 382
TABLE 550 SPAIN: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION) 382
TABLE 551 SPAIN: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 383
TABLE 552 SPAIN: MEMBRANE FILTERS MARKET, BY MATERIAL, 2022–2029 (USD MILLION) 383
TABLE 553 SPAIN: DEPTH FILTERS MARKET, BY TYPE OF MEDIA, 2022–2029 (USD MILLION) 384
TABLE 554 SPAIN: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 384
TABLE 555 SPAIN: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET, BY TYPE,
2022–2029 (USD MILLION) 385
TABLE 556 SPAIN: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION) 385
TABLE 557 SPAIN: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 385
TABLE 558 SPAIN: PHARMACEUTICAL FILTRATION MARKET, BY TYPE,
2022–2029 (USD MILLION) 386
TABLE 559 SPAIN: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 386
TABLE 560 SPAIN: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 387
TABLE 561 SPAIN: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 387
TABLE 562 SPAIN: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION,
2022–2029 (USD MILLION) 388
TABLE 563 SPAIN: PHARMACEUTICAL FILTRATION MARKET, BY END USER,
2022–2029 (USD MILLION) 388
TABLE 564 SWITZERLAND: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 389
TABLE 565 SWITZERLAND: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 389
TABLE 566 SWITZERLAND: PHARMACEUTICAL FILTERS MARKET, BY TYPE,
2022–2029 (USD MILLION) 390
TABLE 567 SWITZERLAND: MEMBRANE FILTERS MARKET, BY MATERIAL,
2022–2029 (USD MILLION) 390
TABLE 568 SWITZERLAND: DEPTH FILTERS MARKET, BY TYPE OF MEDIA,
2022–2029 (USD MILLION) 391
TABLE 569 SWITZERLAND: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 391
TABLE 570 SWITZERLAND: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET, BY TYPE, 2022–2029 (USD MILLION) 392
TABLE 571 SWITZERLAND: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 392
TABLE 572 SWITZERLAND: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 392
TABLE 573 SWITZERLAND: PHARMACEUTICAL FILTRATION MARKET, BY TYPE,
2022–2029 (USD MILLION) 393
TABLE 574 SWITZERLAND: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 393
TABLE 575 SWITZERLAND: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 394
TABLE 576 SWITZERLAND: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 394
TABLE 577 SWITZERLAND: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 395
TABLE 578 SWITZERLAND: PHARMACEUTICAL FILTRATION MARKET, BY END USER,
2022–2029 (USD MILLION) 395
TABLE 579 REST OF EUROPE: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 396
TABLE 580 REST OF EUROPE: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 396
TABLE 581 REST OF EUROPE: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET,
BY FILTERS, 2022–2029 (USD MILLION) 397
TABLE 582 REST OF EUROPE: MEMBRANE FILTERS MARKET, BY MATERIAL,
2022–2029 (USD MILLION) 397
TABLE 583 REST OF EUROPE: DEPTH FILTERS MARKET, BY TYPE OF MEDIA,
2022–2029 (USD MILLION) 398
TABLE 584 REST OF EUROPE: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 398
TABLE 585 REST OF EUROPE: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 399
TABLE 586 REST OF EUROPE: PHARMACEUTICAL FILTRATION SYSTEMS MARKET,
BY TYPE, 2022–2029 (USD MILLION) 399
TABLE 587 REST OF EUROPE: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 399
TABLE 588 REST OF EUROPE: PHARMACEUTICAL FILTRATION MARKET, BY TYPE,
2022–2029 (USD MILLION) 400
TABLE 589 REST OF EUROPE: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 400
TABLE 590 REST OF EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 401
TABLE 591 REST OF EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 401
TABLE 592 REST OF EUROPE: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 402
TABLE 593 REST OF EUROPE: PHARMACEUTICAL FILTRATION MARKET, BY END USER,
2022–2029 (USD MILLION) 402
TABLE 594 MACROECONOMIC OUTLOOK FOR PHARMACEUTICAL FILTRATION MARKET
IN ASIA PACIFIC 405
TABLE 595 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 405
TABLE 596 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 406
TABLE 597 ASIA PACIFIC: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 406
TABLE 598 ASIA PACIFIC: PHARMACEUTICAL FILTERS MARKET, BY TYPE,
2022–2029 (USD MILLION) 406
TABLE 599 ASIA PACIFIC: MEMBRANE FILTERS MARKET, BY MATERIAL,
2022–2029 (USD MILLION) 407
TABLE 600 ASIA PACIFIC: DEPTH FILTERS MARKET, BY TYPE OF MEDIA,
2022–2029 (USD MILLION) 407
TABLE 601 ASIA PACIFIC: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 408
TABLE 602 ASIA PACIFIC: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 408
TABLE 603 ASIA PACIFIC: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION) 408
TABLE 604 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 409
TABLE 605 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET, BY TYPE,
2022–2029 (USD MILLION) 409
TABLE 606 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 410
TABLE 607 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 410
TABLE 608 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 411
TABLE 609 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 411
TABLE 610 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET, BY END USER,
2022–2029 (USD MILLION) 411
TABLE 611 CHINA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 412
TABLE 612 CHINA: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION) 413
TABLE 613 CHINA: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 413
TABLE 614 CHINA: MEMBRANE FILTERS MARKET, BY MATERIAL, 2022–2029 (USD MILLION) 413
TABLE 615 CHINA: DEPTH FILTERS MARKET, BY TYPE OF MEDIA, 2022–2029 (USD MILLION) 414
TABLE 616 CHINA: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 414
TABLE 617 CHINA: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET, BY TYPE,
2022–2029 (USD MILLION) 415
TABLE 618 CHINA: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION) 415
TABLE 619 CHINA: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 415
TABLE 620 CHINA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE,
2022–2029 (USD MILLION) 416
TABLE 621 CHINA: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 416
TABLE 622 CHINA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 417
TABLE 623 CHINA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 417
TABLE 624 CHINA: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION,
2022–2029 (USD MILLION) 418
TABLE 625 CHINA: PHARMACEUTICAL FILTRATION MARKET, BY END USER,
2022–2029 (USD MILLION) 418
TABLE 626 JAPAN: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 419
TABLE 627 JAPAN: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION) 420
TABLE 628 JAPAN: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 420
TABLE 629 JAPAN: MEMBRANE FILTERS MARKET, BY MATERIAL, 2022–2029 (USD MILLION) 421
TABLE 630 JAPAN: DEPTH FILTERS MARKET, BY TYPE OF MEDIA, 2022–2029 (USD MILLION) 421
TABLE 631 JAPAN: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 422
TABLE 632 JAPAN: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET, BY TYPE,
2022–2029 (USD MILLION) 422
TABLE 633 JAPAN: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION) 422
TABLE 634 JAPAN: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 423
TABLE 635 JAPAN: PHARMACEUTICAL FILTRATION MARKET, BY TYPE,
2022–2029 (USD MILLION) 423
TABLE 636 JAPAN: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 423
TABLE 637 JAPAN: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 424
TABLE 638 JAPAN: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 424
TABLE 639 JAPAN: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION,
2022–2029 (USD MILLION) 425
TABLE 640 JAPAN: PHARMACEUTICAL FILTRATION MARKET, BY END USER,
2022–2029 (USD MILLION) 425
TABLE 641 INDIA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 426
TABLE 642 INDIA: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION) 426
TABLE 643 INDIA: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 427
TABLE 644 INDIA: MEMBRANE FILTERS MARKET, BY MATERIAL, 2022–2029 (USD MILLION) 427
TABLE 645 INDIA: DEPTH FILTERS MARKET, BY TYPE OF MEDIA, 2022–2029 (USD MILLION) 428
TABLE 646 INDIA: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 428
TABLE 647 INDIA: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET, BY TYPE,
2022–2029 (USD MILLION) 429
TABLE 648 INDIA: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION) 429
TABLE 649 INDIA: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 429
TABLE 650 INDIA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE,
2022–2029 (USD MILLION) 430
TABLE 651 INDIA: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 430
TABLE 652 INDIA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 431
TABLE 653 INDIA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 431
TABLE 654 INDIA: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION,
2022–2029 (USD MILLION) 432
TABLE 655 INDIA: PHARMACEUTICAL FILTRATION MARKET, BY END USER,
2022–2029 (USD MILLION) 432
TABLE 656 SOUTH KOREA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 433
TABLE 657 SOUTH KOREA: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 433
TABLE 658 SOUTH KOREA: PHARMACEUTICAL FILTERS MARKET, BY TYPE,
2022–2029 (USD MILLION) 433
TABLE 659 SOUTH KOREA: MEMBRANE FILTERS MARKET, BY MATERIAL,
2022–2029 (USD MILLION) 434
TABLE 660 SOUTH KOREA: DEPTH FILTERS MARKET, BY TYPE OF MEDIA,
2022–2029 (USD MILLION) 434
TABLE 661 SOUTH KOREA: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 435
TABLE 662 SOUTH KOREA: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET, BY TYPE, 2022–2029 (USD MILLION) 435
TABLE 663 SOUTH KOREA: PHARMACEUTICAL FILTRATION SYSTEMS MARKET,
BY TYPE, 2022–2029 (USD MILLION) 436
TABLE 664 SOUTH KOREA: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 436
TABLE 665 SOUTH KOREA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE,
2022–2029 (USD MILLION) 436
TABLE 666 SOUTH KOREA: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 437
TABLE 667 SOUTH KOREA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 437
TABLE 668 SOUTH KOREA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 438
TABLE 669 SOUTH KOREA: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 438
TABLE 670 SOUTH KOREA: PHARMACEUTICAL FILTRATION MARKET, BY END USER,
2022–2029 (USD MILLION) 439
TABLE 671 AUSTRALIA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 439
TABLE 672 AUSTRALIA: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 440
TABLE 673 AUSTRALIA: PHARMACEUTICAL FILTERS MARKET, BY TYPE,
2022–2029 (USD MILLION) 440
TABLE 674 AUSTRALIA: MEMBRANE FILTERS MARKET, BY MATERIAL,
2022–2029 (USD MILLION) 441
TABLE 675 AUSTRALIA: DEPTH FILTERS MARKET, BY TYPE OF MEDIA,
2022–2029 (USD MILLION) 441
TABLE 676 AUSTRALIA: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 442
TABLE 677 AUSTRALIA: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET, BY TYPE, 2022–2029 (USD MILLION) 442
TABLE 678 AUSTRALIA: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION) 442
TABLE 679 AUSTRALIA: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 443
TABLE 680 AUSTRALIA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE,
2022–2029 (USD MILLION) 443
TABLE 681 AUSTRALIA: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 443
TABLE 682 AUSTRALIA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 444
TABLE 683 AUSTRALIA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 444
TABLE 684 AUSTRALIA: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 445
TABLE 685 AUSTRALIA: PHARMACEUTICAL FILTRATION MARKET, BY END USER,
2022–2029 (USD MILLION) 445
TABLE 686 REST OF ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 446
TABLE 687 REST OF ASIA PACIFIC: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 446
TABLE 688 REST OF ASIA PACIFIC: PHARMACEUTICAL FILTERS MARKET, BY TYPE,
2022–2029 (USD MILLION) 447
TABLE 689 REST OF ASIA PACIFIC: MEMBRANE FILTERS MARKET, BY MATERIAL,
2022–2029 (USD MILLION) 447
TABLE 690 REST OF ASIA PACIFIC: DEPTH FILTERS MARKET, BY TYPE OF MEDIA,
2022–2029 (USD MILLION) 448
TABLE 691 REST OF ASIA PACIFIC: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 448
TABLE 692 REST OF ASIA PACIFIC: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 449
TABLE 693 REST OF ASIA PACIFIC: PHARMACEUTICAL FILTRATION SYSTEMS MARKET,
BY TYPE, 2022–2029 (USD MILLION) 449
TABLE 694 REST OF ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 449
TABLE 695 REST OF ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION) 450
TABLE 696 REST OF ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 450
TABLE 697 REST OF ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 451
TABLE 698 REST OF ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 451
TABLE 699 REST OF ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 452
TABLE 700 REST OF ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET, BY END USER, 2022–2029 (USD MILLION) 452
TABLE 701 MACROECONOMIC OUTLOOK FOR PHARMACEUTICAL FILTRATION MARKET IN LATIN AMERICA 454
TABLE 702 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 454
TABLE 703 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 454
TABLE 704 LATIN AMERICA: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 455
TABLE 705 LATIN AMERICA: PHARMACEUTICAL FILTERS MARKET, BY TYPE,
2022–2029 (USD MILLION) 455
TABLE 706 LATIN AMERICA: MEMBRANE FILTERS MARKET, BY MATERIAL,
2022–2029 (USD MILLION) 456
TABLE 707 LATIN AMERICA: DEPTH FILTERS MARKET, BY TYPE OF MEDIA,
2022–2029 (USD MILLION) 456
TABLE 708 LATIN AMERICA: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 457
TABLE 709 LATIN AMERICA: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET, BY TYPE, 2022–2029 (USD MILLION) 457
TABLE 710 LATIN AMERICA: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 457
TABLE 711 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 458
TABLE 712 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE,
2022–2029 (USD MILLION) 458
TABLE 713 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 458
TABLE 714 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 459
TABLE 715 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 459
TABLE 716 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 460
TABLE 717 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY END USER,
2022–2029 (USD MILLION) 460
TABLE 718 BRAZIL: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 461
TABLE 719 BRAZIL: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION) 461
TABLE 720 BRAZIL: PHARMACEUTICAL FILTERS MARKET, BY TYPE,
2022–2029 (USD MILLION) 461
TABLE 721 BRAZIL: MEMBRANE FILTERS MARKET, BY MATERIAL, 2022–2029 (USD MILLION) 462
TABLE 722 BRAZIL: DEPTH FILTERS MARKET, BY TYPE OF MEDIA, 2022–2029 (USD MILLION) 462
TABLE 723 BRAZIL: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 463
TABLE 724 BRAZIL: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET, BY TYPE,
2022–2029 (USD MILLION) 463
TABLE 725 BRAZIL: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION) 463
TABLE 726 BRAZIL: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 464
TABLE 727 BRAZIL: PHARMACEUTICAL FILTRATION MARKET, BY TYPE,
2022–2029 (USD MILLION) 464
TABLE 728 BRAZIL: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 464
TABLE 729 BRAZIL: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 465
TABLE 730 BRAZIL: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 465
TABLE 731 BRAZIL: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION,
2022–2029 (USD MILLION) 466
TABLE 732 BRAZIL: PHARMACEUTICAL FILTRATION MARKET, BY END USER,
2022–2029 (USD MILLION) 466
TABLE 733 MEXICO: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 467
TABLE 734 MEXICO: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION) 467
TABLE 735 MEXICO: PHARMACEUTICAL FILTERS MARKET, BY TYPE,
2022–2029 (USD MILLION) 467
TABLE 736 MEXICO: MEMBRANE FILTERS MARKET, BY MATERIAL, 2022–2029 (USD MILLION) 468
TABLE 737 MEXICO: DEPTH FILTERS MARKET, BY TYPE OF MEDIA, 2022–2029 (USD MILLION) 468
TABLE 738 MEXICO: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 469
TABLE 739 MEXICO: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET, BY TYPE,
2022–2029 (USD MILLION) 469
TABLE 740 MEXICO: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION) 469
TABLE 741 MEXICO: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 470
TABLE 742 MEXICO: PHARMACEUTICAL FILTRATION MARKET, BY TYPE,
2022–2029 (USD MILLION) 470
TABLE 743 MEXICO: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 470
TABLE 744 MEXICO: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 471
TABLE 745 MEXICO: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 471
TABLE 746 MEXICO: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 472
TABLE 747 MEXICO: PHARMACEUTICAL FILTRATION MARKET, BY END USER,
2022–2029 (USD MILLION) 472
TABLE 748 REST OF LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 473
TABLE 749 REST OF LATIN AMERICA: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 473
TABLE 750 REST OF LATIN AMERICA: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 473
TABLE 751 REST OF LATIN AMERICA: MEMBRANE FILTERS MARKET, BY MATERIAL,
2022–2029 (USD MILLION) 474
TABLE 752 REST OF LATIN AMERICA: DEPTH FILTERS MARKET, BY TYPE OF MEDIA,
2022–2029 (USD MILLION) 474
TABLE 753 REST OF LATIN AMERICA: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 475
TABLE 754 REST OF LATIN AMERICA: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 475
TABLE 755 REST OF LATIN AMERICA: PHARMACEUTICAL FILTRATION SYSTEMS MARKET,
BY TYPE, 2022–2029 (USD MILLION) 475
TABLE 756 REST OF LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 476
TABLE 757 REST OF LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION) 476
TABLE 758 REST OF LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET,
BY APPLICATION, 2022–2029 (USD MILLION) 476
TABLE 759 REST OF LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 477
TABLE 760 REST OF LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 477
TABLE 761 REST OF LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 478
TABLE 762 REST OF LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET,
BY END USER, 2022–2029 (USD MILLION) 478
TABLE 763 MACROECONOMIC OUTLOOK FOR PHARMACEUTICAL FILTRATION MARKET IN MIDDLE EAST 479
TABLE 764 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 480
TABLE 765 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 480
TABLE 766 MIDDLE EAST: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 480
TABLE 767 MIDDLE EAST: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 481
TABLE 768 MIDDLE EAST: MEMBRANE FILTERS MARKET, BY MATERIAL,
2022–2029 (USD MILLION) 481
TABLE 769 MIDDLE EAST: DEPTH FILTERS MARKET, BY TYPE OF MEDIA,
2022–2029 (USD MILLION) 482
TABLE 770 MIDDLE EAST: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 482
TABLE 771 MIDDLE EAST: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 483
TABLE 772 MIDDLE EAST: PHARMACEUTICAL FILTRATION SYSTEMS MARKET,
BY TYPE, 2022–2029 (USD MILLION) 483
TABLE 773 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 483
TABLE 774 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET, BY TYPE,
2022–2029 (USD MILLION) 484
TABLE 775 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 484
TABLE 776 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 485
TABLE 777 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 485
TABLE 778 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 486
TABLE 779 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET, BY END USER,
2022–2029 (USD MILLION) 486
TABLE 780 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 487
TABLE 781 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 487
TABLE 782 GCC COUNTRIES: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 487
TABLE 783 GCC COUNTRIES: PHARMACEUTICAL FILTERS MARKET, BY TYPE,
2022–2029 (USD MILLION) 488
TABLE 784 GCC COUNTRIES: MEMBRANE FILTERS MARKET, BY MATERIAL,
2022–2029 (USD MILLION) 488
TABLE 785 GCC COUNTRIES: DEPTH FILTERS MARKET, BY TYPE OF MEDIA,
2022–2029 (USD MILLION) 489
TABLE 786 GCC COUNTRIES: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 489
TABLE 787 GCC COUNTRIES: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET, BY TYPE, 2022–2029 (USD MILLION) 490
TABLE 788 GCC COUNTRIES: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 490
TABLE 789 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 490
TABLE 790 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET, BY TYPE,
2022–2029 (USD MILLION) 491
TABLE 791 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 491
TABLE 792 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 492
TABLE 793 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 492
TABLE 794 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 493
TABLE 795 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET, BY END USER,
2022–2029 (USD MILLION) 493
TABLE 796 SAUDI ARABIA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 494
TABLE 797 SAUDI ARABIA: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 494
TABLE 798 SAUDI ARABIA: PHARMACEUTICAL FILTERS MARKET, BY TYPE,
2022–2029 (USD MILLION) 495
TABLE 799 SAUDI ARABIA: MEMBRANE FILTERS MARKET, BY MATERIAL,
2022–2029 (USD MILLION) 495
TABLE 800 SAUDI ARABIA: DEPTH FILTERS MARKET, BY TYPE OF MEDIA,
2022–2029 (USD MILLION) 496
TABLE 801 SAUDI ARABIA: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 496
TABLE 802 SAUDI ARABIA: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 497
TABLE 803 SAUDI ARABIA: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION) 497
TABLE 804 SAUDI ARABIA: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 497
TABLE 805 SAUDI ARABIA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE,
2022–2029 (USD MILLION) 498
TABLE 806 SAUDI ARABIA: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 498
TABLE 807 SAUDI ARABIA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 499
TABLE 808 SAUDI ARABIA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 499
TABLE 809 SAUDI ARABIA: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 500
TABLE 810 SAUDI ARABIA: PHARMACEUTICAL FILTRATION MARKET, BY END USER,
2022–2029 (USD MILLION) 500
TABLE 811 UAE: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 501
TABLE 812 UAE: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 501
TABLE 813 UAE: PHARMACEUTICAL FILTRATION FILTERS MARKET, BY TYPE,
2022–2029 (USD MILLION) 501
TABLE 814 UAE: MEMBRANE FILTERS MARKET, BY MATERIAL, 2022–2029 (USD MILLION) 502
TABLE 815 UAE: DEPTH FILTERS MARKET, BY TYPE OF MEDIA, 2022–2029 (USD MILLION) 502
TABLE 816 UAE: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 503
TABLE 817 UAE: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET, BY TYPE,
2022–2029 (USD MILLION) 503
TABLE 818 UAE: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION) 503
TABLE 819 UAE: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 504
TABLE 820 UAE: PHARMACEUTICAL FILTRATION MARKET, BY TYPE,
2022–2029 (USD MILLION) 504
TABLE 821 UAE: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 504
TABLE 822 UAE: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 505
TABLE 823 UAE: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION,
BY TYPE, 2022–2029 (USD MILLION) 505
TABLE 824 UAE: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION,
2022–2029 (USD MILLION) 506
TABLE 825 UAE: PHARMACEUTICAL FILTRATION MARKET, BY END USER,
2022–2029 (USD MILLION) 506
TABLE 826 REST OF GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 507
TABLE 827 REST OF GCC COUNTRIES: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 507
TABLE 828 REST OF GCC COUNTRIES: PHARMACEUTICAL FILTERS MARKET, BY FILTERS, 2022–2029 (USD MILLION) 507
TABLE 829 REST OF GCC COUNTRIES: MEMBRANE FILTERS MARKET, BY MATERIAL,
2022–2029 (USD MILLION) 508
TABLE 830 REST OF GCC COUNTRIES: DEPTH FILTERS MARKET, BY TYPE OF MEDIA,
2022–2029 (USD MILLION) 508
TABLE 831 REST OF GCC COUNTRIES: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 509
TABLE 832 REST OF GCC COUNTRIES: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET, BY TYPE, 2022–2029 (USD MILLION) 509
TABLE 833 REST OF GCC COUNTRIES: PHARMACEUTICAL FILTRATION SYSTEMS MARKET,
BY TYPE, 2022–2029 (USD MILLION) 509
TABLE 834 REST OF GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET,
BY TECHNIQUE, 2022–2029 (USD MILLION) 510
TABLE 835 REST OF GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET,
BY TYPE, 2022–2029 (USD MILLION) 510
TABLE 836 REST OF GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET,
BY APPLICATION, 2022–2029 (USD MILLION) 510
TABLE 837 REST OF GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 511
TABLE 838 REST OF GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 511
TABLE 839 REST OF GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 512
TABLE 840 REST OF GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET, BY END USER, 2022–2029 (USD MILLION) 512
TABLE 841 REST OF MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 513
TABLE 842 REST OF MIDDLE EAST: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 513
TABLE 843 REST OF MIDDLE EAST: PHARMACEUTICAL FILTERS MARKET, BY TYPE,
2022–2029 (USD MILLION) 513
TABLE 844 REST OF MIDDLE EAST: MEMBRANE FILTERS MARKET, BY MATERIAL,
2022–2029 (USD MILLION) 514
TABLE 845 REST OF MIDDLE EAST: DEPTH FILTERS MARKET, BY TYPE OF MEDIA,
2022–2029 (USD MILLION) 514
TABLE 846 REST OF MIDDLE EAST: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 515
TABLE 847 REST OF MIDDLE EAST: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 515
TABLE 848 REST OF MIDDLE EAST: PHARMACEUTICAL FILTRATION SYSTEMS MARKET,
BY TYPE, 2022–2029 (USD MILLION) 515
TABLE 849 REST OF MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 516
TABLE 850 REST OF MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET, BY TYPE,
2022–2029 (USD MILLION) 516
TABLE 851 REST OF MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 517
TABLE 852 REST OF MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 517
TABLE 853 REST OF MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 518
TABLE 854 REST OF MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 518
TABLE 855 REST OF MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET, BY END USER, 2022–2029 (USD MILLION) 518
TABLE 856 MACROECONOMIC OUTLOOK FOR PHARMACEUTICAL FILTRATION MARKET
IN AFRICA 520
TABLE 857 AFRICA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 520
TABLE 858 AFRICA: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION) 520
TABLE 859 AFRICA: PHARMACEUTICAL FILTERS MARKET, BY TYPE,
2022–2029 (USD MILLION) 521
TABLE 860 AFRICA: MEMBRANE FILTERS MARKET, BY MATERIAL, 2022–2029 (USD MILLION) 521
TABLE 861 AFRICA: DEPTH FILTERS MARKET, BY TYPE OF MEDIA, 2022–2029 (USD MILLION) 522
TABLE 862 AFRICA: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 522
TABLE 863 AFRICA: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET, BY TYPE,
2022–2029 (USD MILLION) 523
TABLE 864 AFRICA: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION) 523
TABLE 865 AFRICA: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 523
TABLE 866 AFRICA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE,
2022–2029 (USD MILLION) 524
TABLE 867 AFRICA: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 524
TABLE 868 AFRICA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 525
TABLE 869 AFRICA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 525
TABLE 870 AFRICA: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION,
2022–2029 (USD MILLION) 526
TABLE 871 AFRICA: PHARMACEUTICAL FILTRATION MARKET, BY END USER,
2022–2029 (USD MILLION) 526
TABLE 872 STRATEGIES ADOPTED BY KEY PLAYERS IN PHARMACEUTICAL FILTRATION MARKET, 2022−2024 527
TABLE 873 PHARMACEUTICAL FILTRATION MARKET: DEGREE OF COMPETITION, 2023 530
TABLE 874 PHARMACEUTICAL FILTRATION MARKET: PRODUCT FOOTPRINT 535
TABLE 875 PHARMACEUTICAL FILTRATION MARKET: TECHNIQUE FOOTPRINT 536
TABLE 876 PHARMACEUTICAL FILTRATION MARKET: APPLICATION FOOTPRINT 537
TABLE 877 PHARMACEUTICAL FILTRATION MARKET: REGIONAL FOOTPRINT 539
TABLE 878 PHARMACEUTICAL FILTRATION MARKET: DETAILED LIST OF KEY STARTUPS/SMES 542
TABLE 879 PHARMACEUTICAL FILTRATION: COMPETITIVE BENCHMARKING
OF KEY STARTUPS/SMES 543
TABLE 880 PHARMACEUTICAL FILTRATION MARKET: PRODUCT LAUNCHES,
JANUARY 2022–OCTOBER 2024 546
TABLE 881 PHARMACEUTICAL FILTRATION MARKET: DEALS, JANUARY 2022–OCTOBER 2024 547
TABLE 882 PHARMACEUTICAL FILTRATION MARKET: EXPANSIONS,
JANUARY 2022–OCTOBER 2024 548
TABLE 883 DANAHER CORPORATION: COMPANY OVERVIEW 549
TABLE 884 DANAHER CORPORATION: PRODUCTS OFFERED 550
TABLE 885 DANAHER CORPORATION: PRODUCT LAUNCHES, JANUARY 2022–OCTOBER 2024 556
TABLE 886 DANAHER CORPORATION: DEALS, JANUARY 2022– OCTOBER 2024 557
TABLE 887 DANAHER CORPORATION: EXPANSIONS, JANUARY 2022– OCTOBER 2024 557
TABLE 888 MERCK KGAA: COMPANY OVERVIEW 559
TABLE 889 MERCK KGAA: PRODUCTS OFFERED 560
TABLE 890 MERCK KGAA: EXPANSIONS, JANUARY 2022– OCTOBER 2024 565
TABLE 891 MERCK KGAA: OTHER DEVELOPMENTS, JANUARY 2022– OCTOBER 2024 566
TABLE 892 SARTORIUS AG: COMPANY OVERVIEW 568
TABLE 893 SARTORIUS AG: PRODUCTS OFFERED 569
TABLE 894 SARTORIUS AG: PRODUCT LAUNCHES, JANUARY 2022– OCTOBER 2024 572
TABLE 895 SARTORIUS AG: DEALS, JANUARY 2022–OCTOBER 2024 572
TABLE 896 SARTORIUS AG: EXPANSIONS, JANUARY 2022– OCTOBER 2024 573
TABLE 897 3M COMPANY: COMPANY OVERVIEW 575
TABLE 898 3M COMPANY: PRODUCTS OFFERED 576
TABLE 899 3M COMPANY: PRODUCT LAUNCHES, JANUARY 2022–OCTOBER 2024 579
TABLE 900 3M COMPANY: DEALS, JANUARY 2022–OCTOBER 2024 579
TABLE 901 3M COMPANY: OTHER DEVELOPMENTS, JANUARY 2022–OCTOBER 2024 580
TABLE 902 REPLIGEN CORPORATION: COMPANY OVERVIEW 581
TABLE 903 REPLIGEN CORPORATION: PRODUCTS OFFERED 582
TABLE 904 REPLIGEN CORPORATION: PRODUCT LAUNCHES, JANUARY 2022–OCTOBER 2024 584
TABLE 905 REPLIGEN CORPORATION: DEALS, JANUARY 2022–OCTOBER 2024 584
TABLE 906 PARKER HANNIFIN CORPORATION: COMPANY OVERVIEW 586
TABLE 907 PARKER HANNIFIN CORPORATION: PRODUCTS OFFERED 587
TABLE 908 EATON CORPORATION PLC: COMPANY OVERVIEW 589
TABLE 909 EATON CORPORATION PLC: PRODUCTS OFFERED 591
TABLE 910 EATON CORPORATION PLC: PRODUCT LAUNCHES, JANUARY 2022–OCTOBER 2024 592
TABLE 911 THERMO FISHER SCIENTIFIC, INC.: COMPANY OVERVIEW 593
TABLE 912 THERMO FISHER SCIENTIFIC, INC.: PRODUCTS OFFERED 594
TABLE 913 THERMO FISHER SCIENTIFIC, INC.: EXPANSIONS, JANUARY 2022–OCTOBER 2024 597
TABLE 914 DONALDSON COMPANY, INC.: COMPANY OVERVIEW 599
TABLE 915 DONALDSON COMPANY, INC.: PRODUCTS OFFERED 600
TABLE 916 DONALDSON COMPANY, INC.: DEALS, JANUARY 2022– OCTOBER 2024 601
TABLE 917 DONALDSON COMPANY, INC.: EXPANSIONS, JANUARY 2022– OCTOBER 2024 602
TABLE 918 PORVAIR PLC: COMPANY OVERVIEW 603
TABLE 919 PORVAIR PLC: PRODUCTS OFFERED 604
TABLE 920 PORVAIR PLC: PRODUCT LAUNCHES, JANUARY 2022–OCTOBER 2024 606
TABLE 921 ALFA LAVAL CORPORATE AB: COMPANY OVERVIEW 607
TABLE 922 ALFA LAVAL CORPORATE AB: PRODUCTS OFFERED 608
TABLE 923 ALFA LAVAL CORPORATE AB: PRODUCT LAUNCHES,
JANUARY 2022–OCTOBER 2024 609
TABLE 924 CORNING INCORPORATED: COMPANY OVERVIEW 610
TABLE 925 CORNING INCORPORATED: PRODUCTS OFFERED 611
TABLE 926 MANN+HUMMEL: COMPANY OVERVIEW 614
TABLE 927 MANN+HUMMEL: PRODUCTS OFFERED 615
TABLE 928 MANN+HUMMEL: DEALS, JANUARY 2022–OCTOBER 2024 616
TABLE 929 SAINT-GOBAIN: COMPANY OVERVIEW 617
TABLE 930 SAINT-GOBAIN: PRODUCTS OFFERED 618
TABLE 931 SAINT-GOBAIN: PRODUCT LAUNCHES, JANUARY 2022– OCTOBER 2024 618
TABLE 932 SAINT-GOBAIN: EXPANSIONS, JANUARY 2022– OCTOBER 2024 619
TABLE 933 STERIS PLC: COMPANY OVERVIEW 620
TABLE 934 STERIS PLC: PRODUCTS OFFERED 621
TABLE 935 MEISSNER FILTRATION PRODUCTS, INC.: COMPANY OVERVIEW 622
TABLE 936 AMAZON FILTERS LTD.: COMPANY OVERVIEW 624
TABLE 937 GRAVER TECHNOLOGIES, LLC.: COMPANY OVERVIEW 626
TABLE 938 MMS AG: COMPANY OVERVIEW 628
TABLE 939 ERTELALSOP: COMPANY OVERVIEW 629
TABLE 940 KASAG SWISS AG: COMPANY OVERVIEW 630
TABLE 941 FREUDENBERG FILTRATION TECHNOLOGIES SE & CO. KG: COMPANY OVERVIEW 631
TABLE 942 COLE-PARMER INSTRUMENT COMPANY, LLC: COMPANY OVERVIEW 632
TABLE 943 FILTROX AG: COMPANY OVERVIEW 633
TABLE 944 MEMBRANE SOLUTIONS: COMPANY OVERVIEW 634
LIST OF FIGURES
FIGURE 1 MARKETS COVERED AND REGIONAL SCOPE 56
FIGURE 2 RESEARCH DESIGN 59
FIGURE 3 PHARMACEUTICAL FILTRATION MARKET: BREAKDOWN OF PRIMARIES 62
FIGURE 4 PHARMACEUTICAL FILTRATION MARKET SIZE ESTIMATION
(SUPPLY-SIDE ANALYSIS), 2023 64
FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023 65
FIGURE 6 ILLUSTRATIVE EXAMPLE OF SARTORIUS AG: REVENUE ANALYSIS (2023) 66
FIGURE 7 MARKET SIZE VALIDATION FROM PRIMARY SOURCES 67
FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 68
FIGURE 9 PHARMACEUTICAL FILTRATION MARKET: CAGR PROJECTIONS 69
FIGURE 10 DATA TRIANGULATION METHODOLOGY 71
FIGURE 11 PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2024 VS. 2029 74
FIGURE 12 PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2024 VS. 2029 75
FIGURE 13 PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2024 VS. 2029 75
FIGURE 14 PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2024 VS. 2029 76
FIGURE 15 GEOGRAPHICAL SNAPSHOT OF PHARMACEUTICAL FILTRATION MARKET 77
FIGURE 16 GROWING DEMAND FOR DRUG DISCOVERY & DEVELOPMENT TO DRIVE MARKET 78
FIGURE 17 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN PHARMACEUTICAL
FILTRATION MARKET IN 2023 79
FIGURE 18 CONSUMABLES SEGMENT ACCOUNTED FOR LARGER MARKET SHARE IN 2023 80
FIGURE 19 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT ACCOUNTED FOR LARGEST SHARE 80
FIGURE 20 ASIA PACIFIC COUNTRIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD 81
FIGURE 21 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN PHARMACEUTICAL FILTRATION MARKET 82
FIGURE 22 GLOBAL PHARMACEUTICAL R&D SPENDING, 2021–2030 85
FIGURE 23 PHARMACEUTICAL FILTRATION MARKET: SUPPLY CHAIN ANALYSIS 96
FIGURE 24 VALUE CHAIN ANALYSIS OF PHARMACEUTICAL FILTRATION MARKET 98
FIGURE 25 AVERAGE SELLING PRICE TREND OF KEY PRODUCTS, 2021–2023 100
FIGURE 26 AVERAGE SELLING PRICE OF KEY PRODUCTS, BY REGION, 2023 101
FIGURE 27 PHARMACEUTICAL FILTRATION MARKET: ECOSYSTEM ANALYSIS 102
FIGURE 28 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 105
FIGURE 29 PATENT ANALYSIS, PHARMACEUTICAL FILTRATION MARKET, 2014–2024 106
FIGURE 30 PHARMACEUTICAL FILTRATION MARKET: PORTERS FIVE ANALYSIS 111
FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF PHARMACEUTICAL FILTRATION PRODUCTS 113
FIGURE 32 KEY BUYING CRITERIA FOR END USERS 114
FIGURE 33 NUMBER OF ANTIBODY THERAPEUTICS GRANTED FIRST APPROVAL IN US
OR EU, 2012 TO 2023 261
FIGURE 34 NUMBER OF FDA-APPROVED DRUGS, 2015–2023 312
FIGURE 35 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET SNAPSHOT 326
FIGURE 36 NIH FUNDING IN LAST 10 YEARS (2014–2024) 334
FIGURE 37 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET SNAPSHOT 403
FIGURE 38 PHARMACEUTICAL FILTRATION MARKET: REVENUE ANALYSIS OF KEY PLAYERS, 2019–2023 529
FIGURE 39 PHARMACEUTICAL FILTRATION MARKET: MARKET SHARE ANALYSIS OF KEY PLAYERS, 2023 530
FIGURE 40 PHARMACEUTICAL FILTRATION MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 533
FIGURE 41 PHARMACEUTICAL FILTRATION MARKET: COMPANY FOOTPRINT 534
FIGURE 42 PHARMACEUTICAL FILTRATION MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 541
FIGURE 43 EV/EBITDA OF KEY VENDORS, 2024 544
FIGURE 44 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 544
FIGURE 45 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY PRODUCT 545
FIGURE 46 DANAHER CORPORATION: COMPANY SNAPSHOT (2023) 550
FIGURE 47 MERCK KGAA: COMPANY SNAPSHOT (2023) 560
FIGURE 48 SARTORIUS AG: COMPANY SNAPSHOT (2023) 569
FIGURE 49 3M COMPANY: COMPANY SNAPSHOT (2023) 576
FIGURE 50 REPLIGEN CORPORATION: COMPANY SNAPSHOT (2023) 582
FIGURE 51 PARKER HANNIFIN CORPORATION: COMPANY SNAPSHOT (2023) 587
FIGURE 52 EATON CORPORATION PLC: COMPANY SNAPSHOT (2023) 590
FIGURE 53 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2023) 594
FIGURE 54 DONALDSON COMPANY, INC.: COMPANY SNAPSHOT (2023) 600
FIGURE 55 PORVAIR PLC: COMPANY SNAPSHOT (2023) 604
FIGURE 56 ALFA LAVAL CORPORATE AB: COMPANY SNAPSHOT (2023) 608
FIGURE 57 CORNING INCORPORATED: COMPANY SNAPSHOT (2023) 611
FIGURE 58 MANN+HUMMEL: COMPANY SNAPSHOT (2023) 615
FIGURE 59 SAINT-GOBAIN: COMPANY SNAPSHOT (2023) 617
FIGURE 60 STERIS PLC: COMPANY SNAPSHOT (2023) 621
MarketsandMarkets(マーケッツアンドマーケッツ)は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間~12時間以内(営業日基準)にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨(定価)を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料(ハンドリングチャージ)無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内(関連会社除く)5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100%持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内(営業日基準)
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11